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Abstract
There is substantial evidence to indicate that the Type A
Behavior Pattern is associated with an increased risk of
coronary heart disease.

Recent research has shown that Type

As* as canpared to Type Bs, demonstrate enhanced biochemical
and cardiovascular responses to stressful situations.

These

findings have led researchers to postulate that physiological
reactivity may be one of the mechanisms through which Type A
behavior confers coronary risk.

The present study was designed

to investigate physiological and psychological reactivity in
Type A and Type B cardiac patients exposed to a cardiac
catheterization. The effects of drugs (i.e., none versus
beta-blockers and calcium channel blockers) on the response to
stress was systematically evaluated.

Dependent measures,

adrenocorticotropic hormone (ACTH), systolic blood pressure
(SBP), diastolic blood pressure (DBP), heart rate (HR), state
anxiety (STAI-state), and Total Mood Disturbance (TMD), were
obtained prior to cardiac catheterization (day 1) and 24 hours
later (day 2).

A 2 x 2 x 2 (Behavior Type x Drug Group x Day)

analysis of variance with repeated measures on day revealed
significant main effects of day for ACTH, SBP, and state
anxiety.

A significant main effect for drug group

and a

significant Behavior Type x Drug interaction was revealed for
ACTH.

A significant Behavior Type x Day interaction was found

for SBP.

An additional analysis investigating the responses of
ix

extreme Type A and Type B subjects revealed significant main
effects of day for HR and State Anxiety.
present study failed

The results of the

to support previous research

demonstrating that Type A subjects, as carpared to Type B
subjects, exhibit exaggerated responsivity to stress.

Possible

reasons for this failure to find significant A-B differences
are explored.

The major contribution of the present study was

the finding, consistent with previous research, that the target
medications were associated with substantially reduced
responsivity to stress (as measured by ACTH) in Type A cardiac
patients to levels consistent with the response of Type b
cardiac paients.

The clinical and research implications

arising from this finding are discussed.

Continued systematic

evaluation of the effects of medications on reactivity is
strongly recommended.

CHAPTER ONE
Cardiovascular disease is the leading cause of death in the
United States today.
form of this disease.

More than 43 million Americans have seme
Almost five million Americans suffer fran

coronary heart disease (CHD), a form of cardiovascular disease
(American Heart Association, 1985).

Among the cardiovascular

diseases, heart attacks, one of the manifestations of CHD, are the
leading cause of death, accounting for 554,900 deaths in 1982
(American Heart Association, 1985).

Cost to the national economy

in 1985 has been estimated at 72.1 billion dollars, including
costs for hospitalisation, physician and nursing services,
medications, and disability costs (American Heart Association,
1985).

Cardiovascular disease ranks second to respiratory

diseases with respect to days of bed disability and first among
diseases that limit activity and cause the greatest number of
hospital bed days (Levy, 1982).

Recent trends in medicine and

technology, and increasing public awareness, have resulted in sane
decline in cardiovascular mortality.

Despite this, however,

cardiovascular disease remains a problem of significant
proportions (Levy, 1982).
Research examining the participation of behavioral risk
factors involved in CHD has witnessed growing interest (Eliot,
Buell, & Dembroski, 1982) especially because of the evidence from
studies indicating that behavioral risk factors are significantly
related to CHD (Rosenman, Friedman, Straus, WUrm, Kositchek, Hahn,
6 Werthessen, 1964; Haynes, Feinleib, & Kannel, 1980).
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There is
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now a substantial body of literature demonstrating the Type A
Behavior Pattern (Friedman 6 Rosenman, 1959), characterized
primarily by a sense of time urgency, easily aroused hostility,
and competitive achievement striving, is strongly associated with
incidence, and often severity of CHD.
Coronary Heart Disease
Coronary heart disease (CHD) is a clinical term used to
describe that group of cardiovascular diseases in which the
primary symptomatic manifestations are angina pectoris (i.e.,
chest pain secondary to an oxygen defiency in a region or regions
of the heart), myocardial infarction (i.e., a consequence of
coronary artery disease in which irreversible cellular injury and
necrosis occurs secondary to prolonged ischemia), and sudden
cardiac death.

Sudden cardiac death is defined as unexpected,

witnessed death in a subject with or without preexisting heart
disease, who dies in less than one hour following the terminal
event (Kloster & Bristow, 1985).

The major etiologic cause of CHD

is atherosclerosis, an accumulation of fatty deposits in the
coronary arteries that restricts blood flew (Willerson, 1982).
Arteries are blood vessels that flow away from the heart and carry
oxygenated blood to various parts of the body.

The coronary

arteries are those which directly provide oxygen and nourishment
to the heart itself.

The process of atherosclerosis will be

considered in subsequent sections of this paper.
A long list of major and minor cardiovascular risk factors
have been described from epidemiological studies.

According to
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Levy (1982), the major risk factors are age, sex, hypertension,
cigarette smoking, diabetes, high levels of low density
lipoproteins, and deficit levels of high density lipoproteins.
Lew density lipoproteins (LDL) are the major carriers of
cholesterol.

There is a positive association between high levels

of LDL and CHD.

High density lipoproteins (HDL) provide a

protective effect that is as yet not clearly understood.

The HDL

level is inversely related to cardiovascular risk (i.e., the
higher the HDL, the lower the cardiovascular risk).
Hyperlipidemia, defined as serum cholesterol and/or triglycerides
at levels higher than the 95th percentile for controls, is thought
to be a major risk factor for atherosclerosis.
risk factors have also been reported.

A number of mjnor

These are family history of

heart disease, obesity, sedentary lifestyle (or lack of regular
physical activity), and emotional stress (including personality
type).
Aside frcm physical examination, several diagnostic
procedures (e.g., chest x-ray, electrocardiography,
echocardiography, cardiac catheterization) are available to the
physician interested in evaluating cardiac function.

The

following discussion focuses on cardiac catheterization, because
this is the procedure used in the present study.

Cardiac

catheterization (also known as coronary arteriography or coronary
arteriogram) is a powerful diagnostic procedure that allows for
comprehensive assessment of cardiac structure and function.

It

involves the detailed measurement of intracardiac, pressures and
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blood flow and the angiographic visualization of heart and
coronary arteries (Harrison, 1982).

A cardiac catheteterization

is employed when cardiac condition cannot be adequately
established through history, physical exan, or the use of
noninvasive techniques.

It can serve primarily as a method for

providing the anatomic and physiologic details necessary for
planning surgery (e.g., coronary artery bypass surgery).

It can

be used to evaluate the severity of a known cardiovascular
disorder in which there is a discrepancy between syrptcms and
physical findings.

It can also be employed as a diagnostic

procedure in the assessment of suspected cardiovascular disease or
to clarify the presence of symptoms with unknown etiology.

In the

patient who ccnplaihs of recurrent chest pain consistent with
angina pectoris, the cardiac catheterization is a necessary and
invaluable technique for establishing the presence of coronary
artery disease (Wallace, 1982).

It is currently the most reliable

diagnostic test to detect the presence of coronary
atherosclerosis.
Medical Management of CHD
Over the past two decades, remarkable advances have been made
in the management of angina pectoris.

Pharmacologically, three

major classes of drugs have radically changed the medical
treatment of angina (Kloster & Bristcw, 1985).

These are:

(a)

the nitroglycerin (NIG) preparations and related nitrates, (b) the
beta-adrenergic blocking drugs, and (c) the calcium entry blocking
drugs.

These drugs, alone or in combination, are reported to be

5
highly, effective in preventing or relieving chest pain in CHD
patients.

There is seme evidence to suggest that they may reduce

CHD mortality and other complications of coronary atherosclerosis
(Kloster et al., 1985).

Each of these drugs is described briefly

in the following section.

Unless otherwise noted, the majority of

the following information is taken from two sources—

Kloster et

al (1985) and McCall, Walsh, Frolich, & O'Rourke (1985).
Nitrates.

The use of nitrates was introduced 100 years ago

as antianginal agents.
treatment of angina.

Today they remain the mainstay for
These drugs owe much success to their rapid

onset of action with subsequent prompt and complete relief of
pain.

A number of preparations are available including oral,

transdermal, and sublingual forms.

Although the physiological

consequences are not completely understood, it appears that the
main sites of action are the specific receptor sites in vessel
walls that produce dilation of vascular and other smooth muscle
throughout the body.

The most potent effects are on the venous

system, with lesser effects on the large arteries.

The effects of

nitrates on the peripheral veins, the systemic arteries, and the
*

coronary circulation, contribute to the beneficial responses of
decreased myocardial oxygen demand and improved myocardial
perfusion.
Beta-adrenoreceptor blocking drugs.

Beta-adrenoreceptor

blocking drugs are among the most widely prescribed medications.
These drugs, also known as beta antagonists, are competitive
inhibitors of catecholamine binding at beta-adrenergic sites.
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thereby blocking or decreasing the effects of catecholamines.

The

mechanisms of action and the efficacy of these drugs are more
clearly understood than is the case for nitrates.

According to

their sites of action, two types of beta-blockers have been
identified.

Beta-1 drugs block cardiostimulation and lipolysis.

Beta-2 blockers block vasodilation. The cardiac effects of beta-1
antagonists result in decreased heart rate and decreased
myocardial contractility as do all beta blockers.

They do differ

in terms of their non-cardiac effects on beta-2 receptors in the
peripheral circulation and in the bronchi,

this selectivity,

though, is relative because at higher doses, both receptors are
blocked (Durel, Krantz, Bisold, & Lazar, 1965).

Although

beta-antagonists do vary in terms of potency, this is clinically
unimportant because dosages are titrated.

By decreasing heart

rate and contractility, beta blockers reduce myocardial oxygen
demand, and decrease systemic arterial blood pressure and cardiac
output. Systemic vascular resistance is increased.
Beta-antagonists also differ, aside frcm their cardioselectivity,
in other ways as well.

Seme (e.g., prcpanolol) have a

quinidine-1 ike effect making them useful in the treatment of
arrhythmias.

Beta-antagonists differ with respect to solubility

with sane being lipid soluble and seme being water soluble.
Although differences do exist, there does not appear to be
any particular advantages or disadvantages associated with any of
them.

They have been reported to be equally effective, resulting

in symptomatic relief in .80 per cent of patients.

Another drug
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may be chosen, however, when certain contraindications exist
(e.g.., congestive heart failure, obstructive airway disease, or
diabetes) or when potentially harmful side effects are anticipated
(e.g., bradycardia).

They are often used in combinations with

nitrates or calcium entry blockers.
Calcium entry blockers.

These drugs represent a

heterogenous group sharing in cannon the ability to inhibit the
movement of calcium ions across myocardial and vascular smooth
muscle.

Three are currently approved for use in the United

States, nifedipine, verapamil, and diltiazem, for the management
of chronic stable angina in patients intolerant (secondary to side
effects or contraindications) or refractory to treatment with
beta-blockers and nitrates.

Calcium entry blockers are also used

to manage coronary artery spasm (a variant of angina).

They are

reported to be at least as effective as beta-antagonists and
nitrates.

The mechanism of action appears to be a decrease of or

inhibition of calcium into the interior of the cell, and thus they
modify a number of calcium-dependent processes (e.g.,
excitation-contraction in vascular smooth muscle).

The direct

cardiovascular effects are qualitatively similar resulting in
decreased force of contraction, dilation of the coronary and
systemic arteries, and slowed heart rate.

All three also reduce

systemic arterial pressure and vascular resistance, thus
decreasing myocardial oxygen demand.
The Type A Behavior pattern
The role of psychosocial factors in cardiovascular disease
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was first empirically studied by two cardiologists, Friedman and
Rosenman.

Their research, which began in the 1950s, resulted in

the formulation of the Type A behavior pattern (TABP). The TABP
is best characterized as a set of overt behaviors which can be
elicited from susceptible individuals given appropriately
challenging environments (Matthews, 1982).

The central elements

of the behavior pattern appear to be a sense of time urgency,
easily aroused hostility, and competitive achievement striving.
Type A, which has been termed the "new" risk factor for CHD
(Price, 1982), has been demonstrated in several epidemiological
studies to be independently associated with an increased incidence
of heart disease (Rosenman et al., 1964; Haynes, Levine, Scotch,
Feinleib, & Kannel, 1978).

The findings of such research,

together with the emergence of the field of behavioral medicine
and the need for a preventive approach to CHD, has resulted in a
recently renewed interest in Type A behavior.

This is reflected,

in part, by the fact that, of all Type A studies published since
1959, greater than half have appeared in the last five years
(Price, 1982).
Epidemiological Studies
As mentioned, the work of cardiologists, Friedman and
Rosenman (1959), set the stage for empirical evaluation of the
role of stress in cardiovascular disease.

Frustrated by the

inability of traditional risk factors, or combinations of these
risk factors, to predict more than half of the new cases of CVD,
these cardiologists began to observe their cardiac patients for
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caramon emotional characteristics.

Over twenty years of study

resulted in the following definition of Type A Behavior:
"A characteristic action-emotion complex which is
exhibited by those individuals who are engaged in a
relatively chronic struggle to obtain an unlimited
number of poorly-defined things from the environment in
»

the shortest period of time, and, if necessary, against
the opposing efforts of other things or persons in the
same environment"

(Friedman & Rosenman, 1974, p. 67).

Persons without this style of behavior, who instead maintain a
more relaxed, unhurried lifestyle, are described as Type B
individuals.

The Type B behavior pattern is often thought of as

being the antithesis of Type A.

This is probably not an accurate

characterization because the Type B individual may possess sane
Type A behaviors, but not to the exaggerated degree that a Type A
will shew them.

Matthews (1982) notes that the exact

constituients of Type b behavior remains a matter of controversy.
In her review of the Type A literature, she concludes that Type A
is not a trait or a discrete typology but is instead thought to
occur on a continuum ranging fran extreme Type A to extreme Type
B.
Friedman and Roserman (1959) characterized Type A by the
following:

"1)

an intense, sustained drive to achieve

self-selected but usually poorly defined goals, 2)
inclination and eagerness to ccnpete, 3)
recognition and advancement, 4)

a profound

a persistent drive for

a continuous involvement in
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multiple and diverse functions constantly subject to time
restrictions (deadlines), 5) a habitual propensity to accelerate
the rate of execution of many physical and mental functions, and
6)

an extraordinary mental and physical alertness" (p. 1286).
The initial research efforts of Friedman and Roserman began

with investigations of possible biochemical correlates that might
acccnpany the TABP*

Friedman, Roserman, and Carroll (1958)

studied 40 male accountants before, during, and after periods of
increased occupational stress.

Type A behavior was assessed using

a personal interview which later became the Stuctured Interview
(Friedman et al., 1964).

Their results indicated that exposure to

a stressful situation led to a marked rise in serum cholesterol
and an acceleration of blood coagulation that was independent of
diet and physical activity.
Friedman et al. (1959) randanly selected three groups of men,
reported to differ only with respect to behavior pattern, from
various occupational levels to further study the results
previously found with the accountants.

Three groups were formed.

Type A, B, and C, and compared with respect to serum cholesterol,
blood clotting time, presence of clinical coronary disease, and
presence of arcus senilis.

Arcus senilis is a term referring to

the presence of a gray opaque ring surrounding the margin of the
cornea and resulting fran lipoid degeneration (Borland, 1982).
The Type C group was similar in behavior to the Type B group but
Group C also showed chronic anxiety.

Results suggested an

overwhelming difference between the groups of men with respect to
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Incidence of heart disease.

Men in group A (fully developed Type

A) were found to be seven times more likely to have clinical
artery disease than men fran Groups B or C.

Group A was also

reported to show significantly higher serum cholesterol levels,
faster clotting times, and three times the incidence of arcus
senilis.

These authors reported that these results were not

attributable to differences in exercise, fat intake, alcohol, or
cigarettes.

They concluded that it was likely that the behavior

pattern accounted for the differences in the dependent variables.
In a new classic prospective study, the Western Collaborative
Group Study (WOGS), Roserman, Friedman, Straus, WUrm, Kositchek,
Hahn, and Werthessen (1964, 1975) examined the predictive
relationship between TABP and CHD.

These authors hypothesized

that if the behavior pattern plays a significant role in
accelerating CHD, then healthy men, without CHD, with this
behavior pattern, should show a higher future incidence of CHD.
Subjects were 3,154 employed males, aged 39 to 59 years, recruited
from ten business organizations in California.

Overt behavior

pattern was assessed using a personal interview, the Structured
Interview.

This interview contained 27 items requiring subjective

interpretation by the examiner.
included in the interview:
achievements, (b)

There were six content areas

(a) history of past social

present drive to achieve, (c) competitive

involvement, (d) time urgency, (e) hostility, and (f) overt
stylistic signs of TABP ( e.g., appearance of urgency, gesturing,
explosive speech). TABP was observed in 1,589 of the men, and
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Type B behavior was determined in 1,565 of the men.

A thorough

history (e.g., history of illness, family history, education,
occupation, physical activity, diet, alcohol, and tobacco use,
etc.) was obtained and dependent variables— serum lipid and
lipoprotein studies, blood coagulation studies, and cardiovascular
examination— were collected at intake and annually for eight to
nine years.

Results at follow up indicated that Type As were

twice as likely to develop CHD than Type B subjects.

In addition,

Type As, as compared to Bs, were found to have:

five times

(a)

the frequency of suffering a second myocardial infarction (MI),
(b)

twice the frequency of fatal Mis, (c)

twice the degree of

coronary atherosclerosis at post mortem examination in the 25
patients who died.

Eighty-eight per cent, or 22 of 25, of the

subjects who died of CHD were assessed at intake as Type A.
Rosenman et al. (1975) reported that this predictive association
between Type A and CHD was not attributable to traditional risk
factors.

These authors suggested that the TABP should be

considered prominent among the major risk factors for CVD.

They

emphasized that Type A was not an artifact of other risk factors
and that the pathogenic force of the behavior pattern was not due
to other risk factors.

They speculated that the danger associated

with Type A behavior might operate through neurohumoral
mechanisms.
Twenty-five of the subjects from the WCGS, were later found
to show that evidence of a "silent MI" (by electrocardiography)
that was unknown to the subjects or the WCGS investigators at the
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time of data collection.

Jenkins (1966), with the cooperation of

Friedman and Bosenman, designed a study intended to objectify the
components of TABP and to examine the behavioral and biochemical
attributes of these men identified as having suffered from "silent
Mis".

Two control groups were used;

and occupation, and (b)

(a)

a group matched for age

a group matched on age, occupation, and

behavior (A or B). Both control groups were found to be free of
any signs of CHD.

As in the original VJCGS, the scores of the six

behavior components and biochemical data were analyzed.

Regarding

behavior type, it was found that the scores from the "silent
infarct" subjects were significantly higher than the control group
scores on record of past achievements, manifest hostility, and
total score.

Further, the men in the "silent infarct" group who

scored high on impatience and time urgency also had a history of
higher achievement with regard to job status.

With respect to

blood lipid measures, it was reported that subjects with high
levels of hostility showed significantly higher mean serum beta
lipoprotein and beta-alpha lipoprotein ratios.

High scores on the

achievement component were associated with higher total serum
cholesterol levels.

This data led Jenkins (1966) to suggest that,

perhaps, the TABP was not a unidimensional construct, but instead
that various combinations of traits were associated with various
biochemical variables.

The work of Jenkins (1966) lends support

to the findings of the WCGS and also emphasizes the need for a
more objective approach.
Another classic epidemiologic study in the area of Type A
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research was conducted by Haynes et al. (1978, 1980) with the
Framingham Heart Study.

Using 1822 men and wcmen of the

Framingham cohort, aged 45-77, these authors investigated the role
of psychosocial stress in the etiology of blood pressure, serum
cholesterol, and smoking.

Subjects were free of clinical symptoms

of CHD at the initiation of the study.
annually for a period of eight years.

They were followed
In a three part series of

publications resulting from this study, Haynes et al. (1978a,
1978b, 1980) describe the development of the Framingham Type A
Psychosocial Interview and report correlational data on a variety
of psychosocial factors and CHD, including the association between
psychosocial stress and CHD risk at eight year follow-up.

The

interview developed by these authors included 20 scales that can
be grouped into four main catagories:

(a)

Behavior

types— including Framingham Type A Behavior, emotional lability,
anbitiousness, and non-easy going scales, (b)

situational

Stress— including scales measuring situations from job, marriage,
and life, (c)

Somatic strains— including measures of tension,

daily stress, anxiety, and anger, and (d) Sociocultural mobility
including scales measuring occupational changes, promotions,
educational, and job mobility.
Results revealed that the Framingham Type A Behavior Scale
was correlated with anbitiousness, emotional lability, tension,
daily stress, anger symptoms, educational level, and occupational
status.

Sex differences were observed, with women being less

likely to exhibit the Framingham Type A behavior but showing more
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signs of emotional lability, anger, tension, and anxiety.

Less

consistent differences were found between measures of psychosocial
stress and blood pressure or cholesterol.

There was no associaton

found between scores on the Framingham Type A Behavior Scale and
standard CHD risk factors.
At follow-up (eighth or ninth biennial exam), the data
revealed that subjects with all four categories of CHD (i.e.,
uncomplicated angina, angina with or without MI, MI, and total
CHD) scored higher than did subjects without CHD manifestations.
In a multivariate analysis, the Framingham Type A Behavior Scale
differentiated between men with and without MI even when
traditional risk factors were controlled.

The degree of coronary

risk associated with the Type A behavior for men 39-59 was 2.2 for
total CHD, 2.1 for MI, and 2.5 for angina pectoris only.
risk for men aged 45-64 was found to be lowert
2.1 for MI, and 1.8 for angina.

Coronary

1.8 for total CHD,

It is noteworthy that this

association was significant only among men having white-collar
jobs.

The differences between Type A and Type B

blue-collar workers were studied.

disappeared when

When other psychosocial stress

scales were included in the analysis, a scale reflecting aging
worries was found to be the only significant discriminator.

Among

the women, both the Framingham Type A Behavior Scale and the
emotional lability scales were correlated with CHD prevalence when
other risk factors were controlled.

The coronary risk associated

with Type A behavior in women (under 65) was found to be 2.1.
Further, suppressed hostility was found to be an independent
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predictor of CHD among white-collar men and working women.
In conclusion, the work of Haynes et al. (1978a. 1978b, 1980)
supports previous data indicating that Type a behavior is
associated with increased coronary risk, despite the use in this
study of an alternative method for assessing Type A.

However, in

the Framingham study, only white-collar men and employed women
were found to have a significant association between TABP and
increased coronary risk.

The importance of hostility as a

contributing factor was also demonstrated in this study.
Brand, Roserman, Sholtz, and Friedman (1976) compared the
,

t

results of the WCGS and the Framingham study using a multiple
logistic method of analysis.

After adjusting for length of

follow-up, these authors concluded that the CHD risk predictions
from both studies demonstrated good agreement.

They foupd that

the relative risk of CHD (obtained from estimated logistic
coefficients for behavior pattern) was 1.90 and 2.10 for younger
and older decades, respectively.

That is, after traditional risk

factors were adjusted, younger Type A men (aged 39-49) had 1.90
times the risk far CHD than Type B men.

Older men (aged 50-59)

showed 2.10 times the risk of CHD when compared to Type B men in
the same age category.

Brand et al. (1976) also investigated what

CHD reduction would occur if the direct risk associated with TABP
was eliminated. They found that for the younger group, a 28.5 per
cent risk reduction would occur.
reported for the older group.

A 32.3 per cent reduction was

Combining these groups resulted in

a 31 per cent risk reduction rate.
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Disconfirming results on the association between CHD and Type
A behavior have been published.

One recent study (Case, Heller,

Case, & Moss, 1985) reported that Type A (assessed using the JAS)
was not related to cardiac mortality or other disease indices
(e.g., left ventricular ejection fraction) in 516 post-infarct
subjects.

Given this data, sane researchers have argued that the

JAS does not accurately assess Type A.
error are equally likely,

However, other sources of

previous research (Rosenman et al.,

1964) has indicated that Type A individuals are more at risk of
dying from heart attacks.

It is possible, then, that subject

mortality resulted in a biased sanple in this study.

Secondly, it

is conceivable that the experience of having a heart attack might
lead same patients to change their behavior.

At any rate,

negative findings fron one study, that stand in direct contrast to
a substantial number of studies demonstrating positive findings,
do not automatically negate the association between Type A and
CHD.

Instead, the findings of Case et al. (1985) should serve as

an impetus for continued research.
In 1981, the results of the Review Panel on Coronary-Prone
Behavior and Coronary Heart Disease, sponsored by the National
Heart, Blood, and Lung Institute, were published.

This panel

consisted of bianedical and behavioral scientists whose task was
to critically evaluate the existing scientific knowledge on the
proposed association between behavior and CHD.

After an extensive

review of the literature, these panel members concluded:
"The review panel accepts the available body of
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scientific evidence as demonstrating that type A
behavior-as defined by the structured interview..., the
Jenkins Activity Survey .... and the Framingham type A
behavior scale-is associated with an increased risk of
clinically apparent CHD in employed, middle-aged U.S.
citizens.

This risk is greater than that imposed by

age, elevated values of systolic blood pressure and
serum cholesterol, and smoking, and appears to be of the
same order of magnitude as the relative risk associated
with the latter three of these factors" (p. 1200).

Assessment of Type A Behavior
The two most commonly used methods for assessing Type A
behavior are the Structured Inverview (SI, Rosenman et al., 1964)
and the Jenkins Activity Survey (JAS, Jenkins, Rosenman, &
Friedman, 1967).

Both of these measures have been shown in

numerous studies to discriminate CHD subjects from non-CHD
subjects and to predict future incidence of CHD in subjects who
were initially well.

The Framingham Type A Behavior Scale (Haynes

et al., 1978, 1980) has also been found to have these properties,
but aside from the Framingham Heart Study, it has not been widely
used.

Other Type A measures have also been developed (e.g.,

Bortner Rating Scale, Bortner, 1969) but, as yet, these measures
have not been shown to have a predictive association with CHD.
Structured interview . The SI (Rosenman et al., 1964) is a
25 item provocative interview situation in which Type A assessment
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is based on the voice stylistics, psychanotor behaviors, and
verbal content of the respondent (Roserman, 1978).

It was

developed at the Harold Brunn Institute in San Francisco,
California for use in the Western Collaborative Group Study
(WOGS).

It is best characterized as a challenge situation in

which a trained interviewer/observer, attempts to bring out covert
Type A behaviors (Rosenman, 1978).

Sane of the questions are

dependent solely on verbal content of the response (e.g.,"Do you
think you drive harder to accomplish things than most of your
associates?"),

other questions are asked in such a way as to

elicit Type A behavior.

For example, the interviewer asks the

subject a question in a deliberately slew, hesitant fashion,
anticipating the Type A subject to became annoyed and/or interrupt
the interviewer.

Subjective assessment is then made based on the

presence of observed motor and verbal stylistics thought to
characterize the Type A individual (e.g., rapid, loud, emphatic
speech; frequent use of gestures; frequent interruptions of the
interviewer).

Four assessment catagories are used:

developed Type A (A-l), (b)
(c)

(a)

Fully

Incompletely developed Type A (A-2),

Absence of Type A (Type B), and (d)

Type X in which

catagorization is not possible secondary to an equal
representation of both Type A and Type B.
An 80 per cent test-retest agreement rate has been reported
for the SI.

Interrater reliability estimates range from .75 to

.90 (Rosenman, 1978).

The validity of the SI has been well

documented as subsequent sections of this paper will
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illustrate.
Jenkins Activity Survey

The SI, although shown to be

reliable and valid, is not necessarily the ideal method for the
assessment of Type A Behavior.

it is not truly objective and does

not allow for numerical quantification (Roserman, 1978).

It

requires specialized training, supervised experience, and periodic
quality control in the form of monitoring recorded interviews so
that observer bias can be prevented (Jenkins, 1978).

some authors

have noted that it may have limited applicability to some
practitioners because of these factors and the fact that findings
may be largely dependent on the interviewers' skill (Jenkins,
Friedman, & Roeerman, 1967).

The Jenkins Activity Survey (JAS,

Jenkins et al., 1967) was developed to duplicate the SI
psychometrically with the aim of providing a more standard,
objective approach to the assessment of Type A behavior.
The JAS (Form C) is a self-report, machine-scorable
questionnaire.

It uses a multiple choice response format

requiring the repondent to choose which response is most true.

An

Overall Type A score is derived along with three factor
scores— Speed and Impatience (Factor S), Job Involvement (Factor
J), and Hard-Driving and Competitive (Factor H).
As mentioned, the JAS was developed to duplicate the SI.
Jenkins worked closely with Friedman and Roserman learning the SI
and observing many SI assessments.

Frcm this, he developed an

original item pool of 64 questions. Instead of relying on the face
validity of the 64 original items, the JAS was subjected to a

21

series of empirical analyses using subjects and data originally
collected for the WCGS.

In 1964, the experimental version of the

JAS was administered to 120 men in the WCGS whose behavior pattern
had been originally assessed using the SI.

Forty items of the

exprimental JAS significantly discriminated between Si-determined
Type As and Type Bs.

These 40 items, along with an additional 21

items, comprised the first edition of the JAS (Jenkins, Rosenman,
& Zyzanski, 1965).

This version was empirically validated using

2,951 men of the WCGS assessed by the SI as Type A or Type B at
test (1960) and retest two years later.
into three goups:

(a)

These men were divided

400 Type As and 307 Type Bs, (b)

As and 509 Type Bs, and (c)

475 Type

an independent sample of 409 men.

The responses of Group 1 were used to scale items and weight
response alternatives so that weighted scores could be treated as
a continuous variable on an approximately equal interval scale and
so that there would be a maximum distinction between criterion
groups.

Group 2 served as a cross-validation sample using

weighted response items which significantly discriminated between
As and Bs in group 1.

A discriminant function analysis (using 31,

28, 24, and 19 items) was applied to the items surviving this
cross-validation in order to compare for item sensitivity and
specificity with respect to the identification of Type A behavior.
The 19 item equation was found to be the best predictor of Type A
behavior.

These 19 items were retained and cross-validated using

group 3.
An approximately normal distribution was found with the
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scores of all 2,951 men tested.

Scores were transformed to yield

a mean of 0.00 and a standard deviation of 10.0.

Subjects scoring

greater than or less than one standard deviation from the mean
were found to be correctly classified as Type A or Type B by both
the SI and the JAS.

The intermediate scores were found to be less

accurate for predicting Type A behavior.

The level of agreement

between the 1965 JAS and the 1960 and 1962 SI was determined using
the third group. A 73 per cent agreement rate was found.

Using

only extreme scores (i.e., greater than or less than one standard
deviation frcm the mean) resulted in a 90 per cent agreement rate
(Jenkins, Zyzanski, & Rosenman, 1971).

Jenkins et al. (1979)

reported these to reflect respectable levels of agreement
considering the change in mode of data collection and the fact
that three years had elapsed since the most recent SI.
A second edition of the JAS was published in 1966.

Redundant

items or items with less than adequate psychometric properties
were dropped for this edition and several new items were added.
This 57-item version was then validated and cross-validated in
much the same way as was done with the 1965 version.

Twenty-six

items were found to discriminate between Type A and Type B men.
Some of these items were the same as were found with the 1965
version, although a number of new items emerged.

Cross-validation

procedures revealed a 71 per cent agreement rate between the 1966
JAS and the 1960 and 1962 SI.
In order to address the question of whether Type A behavior
was a single syndrome or an aggregation of subsyndrcmes, a series
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of factor analytic procedures were conducted.

Using the data

obtained from the 1965 and 1966 JAS validation studies, three
factors were identified (Zyzanski & Jenkins. 1970).

These were

labeled as Factor S (Speed and Impatience), Factor J (Job
Involvement), and Factor H (Hard-Driving and Competitive).
Jenkins et al. (1979) described the three factors in the following
ways.

Factor S refers to a perceived sense of time urgency.

Subjects scoring high on this factor tend to be inpatient with
others, are likely to hurry others along, and are prone to
irritability.

Subjects scoring high on Factor J tend to show high

levels of dedication to their job.

They sure likely to work longer

hours, to take work heme with them, and report often being
confronted with deadlines on the job.

High scores on Factor H are

found in individuals who perceive themselves as being serious,
competitive, and hard-working, often feeling as though they put in
much more effort than their collegues.
Another version of the JAS was published in 1969.

On this

occasion, the authors felt that the SI from nine years previous
would be unsuitable to use as validation criteria.
1965 and 1966 editions of the JAS were used.

Instead, the

A discriminant

function analysis was conducted to ascertain the items making the
strongest contribution to each of the four scales.
A fourth revision (Form B) was then published in 1972 which
contained those items shown to discriminate between As and Bs in
the 1969 validation and two new items.

Items containing gender

references were also reworded, making the JAS equally applicable
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to females as well as males.
The nest recent version, Form C, was used in the present
study.

The two experimental items added in Form B were not

included in Form C as they did not load on any of the four JAS
scales.

Form C, then, contains 52 items.

The item composition

and scoring algorithms in Form C are exactly the same as those in
the 1969 edition and Form B.

Therefore, all psychometric data

reported in the JAS Manual (Jenkins et al., 1979) for the 1969
edition and Form B apply equally to Form C.
Jenkins et al. (1979) provides normative data based on the
1969 JAS scores of 2,588 males employed in middle- and
upper-echelon jobs who served as subjects in the WCGS.

Norms on

populations other than this (predominantly males) are also
available.
Measures of reliability of the JAS have been reported.
Test-retest correlation coefficients, using intervals of one to
four years, were found to range from 0.60 to 0.70.

These

correlations were found despite modifications in the successive
editions of the JAS, suggesting that the traits measured by this
instrument are relatively stable for at least up to a four year
period.

Internal consistency, the degree to which items in a

scale measure a unified concept, has also been computed. These
reliability coefficients for all four JAS scales range from 0.73
to 0.85.
The validity of the JAS has been well documented.

Subsequent

sections of this paper will report findings indicating that the
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JAS predicts CHD incidence and severity of atherosclerosis.

As

has been previously mentioned, rates of agreement between the JAS
and the SI range fron 73 to 90 per cent, depending on whether
extreme classifications are used.
Type A and Stress
In light of a growing wealth of evidence indicating the
significant role of Type A behavior in CHD, many researchers have
turned their attention toward investigations aimed at assessing
the possible underlying physiologic mechanisms.

Research, thus

far, has suggested that physiologic responsiveness (i.e.,
reactivity) to emotional stress may be a marker of correlated
pathogenic processess in CHD or might serve as direct contributors
to CHD pathology (Krantz & Manuck, 1982).

Although many

individual difference variables are involved in the cardiovascular
and endocrine response to stress (Krantz et al., 1982), research
by Eliot (1982) and others suggests that seme individuals show
exaggerated cardiovascular responses to challenge situations that
may make them coronary-prone. Results from numerous human and
animal studies (Manuck, Kaplan, & Clarkson, 1983) support this
notion, and suggest that pathogenic states can be evoked, even
with short term exposure to psychological stressors (Krantz et
al., 1982).
Reactivity involves the measurement of changes from baseline
functioning that result from exposure to a laboratory or
naturalistic challenge.

If acute changes, produced by psychologic

stimuli, can be linked to potentially pathogenic states, then
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these responses may serve as more useful predictors than
traditional risk factors that are usually obtained at rest (Krantz
et al., 1982).
Atherosclerosis
Before continuing with a thorough discussion of reactivity,
it may be useful to briefly review the atherosclerotic process in
which most of the coronary artery lesions that result in CHD can
be classified (Wissler,1985). Atherosclerosis can be defined as a
form of arteriosclerosis (i.e., thickening in the walls of the
arterioles) in which lipid filled atheronas (i.e. plagues) form
within the intima and inner media of large and medium sized
arteries (Dorland, 1982).

Of uppermost concern here are those

plagues that form within the walls of the coronary arteries.

It

is beyond the scope of the present paper to review the various
etiologies proposed for atherosclerosis.
referred to Wissler (1985).

The interested reader is

Suffice it to say that one of the

ways that these changes can be brought about is by hemodynamic or
chemical injury (Eliot, 1982).

Hemodynamic injury results frcm

impaired blood flow or turbulence at the site of the lesion.
Chemically, it is also kncwn that certain blood lipids (e.g. low
density lipoproteins as well as cortisol and catecholamines) at
certain levels are toxic to coronary arteries, and thus, can
accelerate the atherosclerotic process and/or prevent normal
healing (Eliot, 1982).

Further, plagues can continue to grow in
*

size secondary to continued lipid and cholesterol deposits, as
well as from the entrance of blood platelets which are released.
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The end result can be arterial stenosis (which can further
restrict blood flow), calcification, arterial spasms (responsible
for seme angina attacks), or worse, ulceration and thrombus (i.e.,
clot) formation.

It is the latter event, the development of a

coronary thrombus, that usually leads to a classical myocardial
infarction (Wissler, 1982).
There is evidence to suggest that Type A persons show
elevated blood pressure, heart rate, catecholamines, ACTH,
cortisol, and serum cholesterol when confronted with appropriate
challenges (Krantz et al., 1982).
sypathetic-adrenal-medullary

Thus, theories relating to the

and pituitary-adrenal-cortical

systems are the pathways through which behaviorally mediated risk
mechanisms may operate (Eliot, 1982).

The catecholamine surges

resulting from sympathetic nervous system activation can have as
consequences the promotion of platelet adhesiveness and
aggregation, arrhythmias, as well as the secretion of a number of
hormones, and a decrease in insulin secretion (Eliot, 1982).
Glucocorticoids, released via the pituitary-adrenal-cortical axis,
promote the development of diabetes, hyperlipidemia, and
hypercholesteremia. Glucocorticoids enhance water diuresis,
decrease circulating lymphocytes, increase platelet counts (which
in turn enhances clotting tendencies), and increases gastric
acidity and pepsin production.

They also block growth hormone

secretion, decrease calcium absorption, increase angiotensin
production, suppress inflammatory responses, lower the electrical
excitation threshold of the brain, and sensitize arterioles to the
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pressor effects of catecholamines (Eliot, 1982).

It should be

noted that, althqugh these systems do appear to affect CHD, the
precise mechanisms through which they operate are still a matter
of speculation (Krantz et al., 1982).

This list of potentially

adverse effects lends further credence to the importance of
examining the mechanisms of reported reactivity in the Type A
individual.
Stress
As mentioned, the two systems thought to be related to
reactivity are the sympathetic-adrenal-medullary system and the
pituitary-adrenal-cortical system.

A mare detailed analysis of

hew these systems are related to stress is necessary.

As

originally defined by Selye in 1936, the term stress in the
present paper will refer to the "nonspecific (that is, ccnrnon)
result of any demand on the body, be it mental arithmetic, somatic
survival, and the accomplishment of our aims" (Selye, 1980, p.
vii). During the course of his research, Selye modified the
definition to more clearly distinguish between pleasant and
unpleasant stress.

He notes, however, that the distinction proves

to be immaterial since it is the intensity of the demand for
readjustment or adaptation that determines the response (Selye,
1974).

The use of the term nonspecific does not imply that all

stress is identical.

The stressor, that agent which produces

stress, will necessarily have its specific effects.

This

specificity of the stressor does not contradict the term
nonspecificity contained in the definition of stress.

Instead,
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the specificity of the stressor can be explained by the stressors
side effects and the' internal and external predisposing factors
that may modify the response.
The definition of stress proposed by Selye is based on his
early research showing that there were three objective indicators
that could be recognized no matter how stress was produced.
indicators were (a)

These

the mobilization of the anterior

pituitary-adrenal axis, (b)

the reliable involution of the

thymico-lymphatic system, (c)

the appearance of peptic ulcers.

The appearance of these events, as well as other nonspecific
indicators, defines the phenomenon of stress, irrespective of
other changes that may occur following exposure to the stressor
(Selye, 1980, p.vii).

It would be misleading, though, to consider

stress as a dichotanous yes-no

type of phenomenon,

according to Selye, exists in varying degrees.

stress,

That is, different

demands of different intensities may not always result in
identical or similar reactions.

In each situation, the role of

stress may be more or less important.
One source of confusion in the stress research involves the
use of different formulations to conceptualize stress (McNamara,
1982).

A frequently used conceptualization is that of stress as

an environmental event.

This approach is most consistent with the

study of the association between the accumulation of life events
and the risk of physical illness.

Holmes and Rahe (1968)

stimulated research in this area by reporting strong positive
, correlations between exposure to a large number of life changes
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and the risk of developing some kind of illness.

It is beyond the

scope of the present paper to review the tremendous proliferation
of research that followed such findings. Suffice it to say, that
such research was strongly criticized for yielding unreliable
scores and including items reflecting illness (Holroyd, 1979).
Babkin and Struening (1976), after an extensive review of the
literature, concluded that life events have not been shown to be
reliable predictors of the probability of future illness.

life

events research, while drawing attention to important sources of
stress, tends to focus on linear associations between independent
and dependent variables.

Rabkin et al. (1976) call for future

research to focus on the assessment of internal mechanians through
which life events may have their impact.
Another well known approach to stress is that of stress as a
response.

This area is best exemplified by the work of Selye and

his description of the General Adaptation syndrome (GAS, Selye,
1936).

The GAS (Selye, 1936) is a nonspecific response of the

body to an intense or noxious demand.

There are three distinct

phases of the GAS— alarm, resistance, and exhaustion.

Selye

(1974) has proposed that prolonged or repeated elicitation of the
GAS, or defects associated with this response, play an inportant
role in a large number of stress-related diseases, including
cardiovascular disease. The changes associated with these phases
are mediated by the release of adrenocorticotropic hormone (ACTH)
which stimulates the release of glucocorticoids, and the
activation of the autonomic nervous system which liberates
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catecholamines from the sympathetic nervous system and by the
adrenal medulla (Selye, 1974).

Thus, "the body responds to

increased physical or psychological demands by releasing
adrenocorticotropin (ACTH) from the anterior pituitary,
glucocorticoids from the adrenal cortex, epinephrine from the
adrenal medulla, and norepinephrine from the sympathetic nerves”
(Axelrod & Reisine, 1984, p. 452).
Although the work of Selye has provided an eloquent
documentation of the pituitary-adrenal axis in reponse to a number
of demands, it falls short of providing information about the role
that psychological variables may play in influencing this
response.

Mason (1968, 1971) has argued that the stress response

is mediated by psychological variables.

A third approach to the

study of stress is the transactional model.

In this approach,

stress is conceptualized as a transaction between a system and its
environment.

Stress is characterized by the cognitive processes

that mediate the adaptive demands to the individual and the
individuals' reponse to them.

Lazarus (1966, 1971), using this

approach, conceptualizes stress as an interaction between
appraisal and coping processes.
Space limitations do not permit an extensive review of each
of the factors involved in the stress response.

The interested

reader is referred to Axelrod et al. (1984) and Mason (1968).

The

focus of the following discussion will be on ACIH, because it is
the hormone measured in the present study.

When pertinent,

however, interactions with other substances will be described.
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Adrenocorticotropic Hormone
The release of ACTH is thought to be the main indicator of
the onset of the "stress syndrome" or GAS (Makara, Palkovits, &
Szentangothai, 1980).

The influence of psychological factors on

the pitiutary-adrenal-cortical system has been, perhaps, the most
extensively studied of the endocrine systems, owing much to the
work of Selye

and to the availability of recently developed

excellent biochemical methods of measurement (Mason, 1968).

Human

ACTH is a 39 amino acid, anterior pituitary polypeptide hormone
(Krieger, 1979) controlled by complex regulatory mechanisms such
as corticotropin releasing factor (CRF), vasopressin,
catecholamines, and possibly other as yet unknown hormones
(Axelrod et al., 1984).
elaboration,

Several of these deserve brief

it is noteworthy that the release of ACIH in animals

by catecholamines at sufficiently high levels (eg., that occurring
during hypoglycemia and with myocardial infarction) can be blocked
by propanolol, a beta-adrenoreceptor blocking drug.

Further,

isoproterenol-induced ACTH secretion has been reported to be
blocked by calcium antagonists or a lack of extracellular calcium
(Reisine, Heisler, & Hook, 1982).
Once secreted, ACIH stimulates synthesis of cortisol (in
humans) which, in turn, serves to inhibit further secretion of
ACTH (Axelrod et al., 1984).

Because alternative methods of ACIH

regulation have been reported, the measurement of changes in
corticosterone (or cortisol) and adrenal weight, the most
frequently used measures of stress, cannot be assumed to reflect
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pituitary ACTH in a quantitative manner (Krieger, 1979).

in

addition, the measurement of ACIH is thought to be at least one
step closer than corticosterone to the site of neural initiation
of the stress response (Vernikos-Danellis & Heybach, 1980).
The response of ACTH to an emotional stimulus is influenced
by both the quality and strength of the stimulus (DeWied, 1980).
Although the pituitary-adrenal system responds to a wide variety
of psychological stimuli, those with an element of novelty,
uncertainty, and

unpredictability (Mason, 1968) or those

resulting in fear, anxiety, and frustration (Selye, 1950), are
among the most potent stressors for system activation, resulting
in reportedly striking responses.

The influence of stress upon

ACTH has been said to be superimposed upon all other regulators of
ACTH.

Regardless of time of day or level of plasma cortisol, the

normal individual responds to major stress with an increase in
ACTH and a consequent increase in cortisol (Daughaday, 1981).
It is critical for researchers in the area to note that there
exists a circadian periodicity for ACTH secretion (Krieger, 1978).
This rhythmicity occurs in episodic, relatively synchronous peaks,
with the majority of upward peaks occurring between 3:00 a.m. and
9:00 a.m. so that the highest ACTH levels are found upon
awakening,

wakening is followed by a downward trend with episodic

peaking (associated with mealtimes) and quiescent periods
(Krieger, 1979).

The normal range for early morning samples is

21-139 picograms per milliliter (pg/fal) of blood plasma.

Late

evening samples range from 20 to 85 pg/fal (Buhmann-Wennhold &
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Nelson, 1979).

ACTH periodicity is reported not to be affected by

stress and is not dependent on corticosterone feedback (Krieger,
1979). There has been sane controversy regarding whether ACIH
rhymicity is normal or abnormal in psychiatric patients.

Krieger

(1978) notes that there appears to now be general agreement that
such periodicity is normal, having perhaps more frequent episodic
release.
Reactivity Studies
Studies show, in general, that Type As, as compared to Bs,
respond to appropriate challenges, be they laboratory induced or
naturalistic, with increases in blood pressure, heart rate,
catecholamines, ACTH, cortisol,-and cholesterol (Krantz et al,
1982).

Hemodynamic and endocrine findings have led researchers to

speculate about the roles of the sympathetic-adrenal-medullary
and pituitary-adrenal-cortical stress response systems.

The

purpose of the present discussion is to relate the results of
numerous studies that have accumulated in this area.
Hew and why the Type A behavior pattern confers coronary risk
can be studied in several ways.

First, do Type As behave in such

a way as to frequently arouse the sympathetic nervous system?

The

greater bulk of the evidence here points to the importance of the
roles of hostility, agressiveness, and competitiveness in Type A
(Matthews, Glass, Rosenman, & Bortner, 1977; Carver & Glass, 1978;
Williams, Haney, Lee, Kong, Blumenthal, & Whalen, 1980; Gentry
Chesney, Gary, Hall, & Harburg, 1982; Barefoot, Dahlstrcm, &
Williams, 1983; Shekelle, Gale, Ostfeld, & Paul, 1983).

These
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investigations, which assess the role of hostility in Type A
behavior, appear to follow two major directions.

First, there are

those studies that have demonstrated the existance of a predictive
association between hostility in initially well subjects and
subsequent development of CHD (Matthews et al., 1977; Barefoot et
al., 1983; Shekelle et al., 1983).

Similarly, Williams et al.

(1980) and Dembroski, MacDougall, Williams, Haney, & Blumenthal
(1985) reported significant positive associations between
hostility and degree of coronary atherosclerosis that was
independent of other factors.
A second way that the role of hostility has been studied is
by subjecting Type As and Bs, primarily college students, to
particularly difficult and frustrating tasks under conditions of
harassment and non-harassment by a confederate.

These studies

(Glass, 1982; Carver & Glass, 1978) support hypotheses suggesting
the critical role of hostility and aggressiveness in the Type a
behavior pattern.

Using a paradigm in which subjects were either

exposed to a harassing or non-harassing confederate to wham they
were to teach a complex perceptual motor task, Carver et al.
(1978) found that Type As, assessed by the student form of the
JAS, delivered significantly higher levels of shock intensity to
the harassing learner than did Bs.
supported these findings.

The work of Glass (1982)

Using a competitive game situation in

which subjects were randomly assigned to harass and no-harass
conditions. Glass (1982) reported significantly greater levels of
systolic blood pressure, heart rate, and catecholamines (i.e.,
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epinephrine) among As, as compared to Bs, that were attributable
to condition.

Glass (1982) concluded that, although competition

alone does not result in significant differences between As and
Bs, the response to an element of hostile interaction results in
enhanced responding among Type A subjects.

These studies provide

evidence, that the role of hostility, with subsequent sympathetic
nervous system activation, may be one of the ways that CHD confers
coronary in Type A persons.
Another question that needs to be addressed when attempting
to explain hew Type A confers coronary risk, is whether there are
seme as yet unidentified components that lead to increased
coronary risk among Type A individuals.

The association between

psychosocial variables (other than Type A) and CHD has been
examined (Dimsdale, Haekett, Block, 6 Hutter, 1978; Jenkins,
Stanton, Klein, Savageau, & Harken, 1983; schweritz, McKelvaln,
Laman, Patterson, Dutton, Yusim, Lester, Kraft, Rochelle, &
Leachman, 1983; Freeman, Fleece, Folks, Cohen-Cole, & Waldo,
1984).

Results thus far have been contradictory.

Some authors

have reported significant positive correlations between Type A and
stressful life events, tension, depressive mood, and anger
(Dimsdale et al., 1978) as well as fatigue, life dissatisfactions,
and sleep disturbance (Jenkins et al., 1983).

Schweritz et al.

(1983) failed to find significant associations between
psychosocial measures and extent of disease.

Finally, one study

(Freeman et al., 1984) reported unexpected results.

These authors

found that the incidence of arrhythmias following coronary artery
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bypass surgery was negatively correlated with measures of
depression and anxiety.

They reported that patients scoring lew

on depression and on anxiety had a greater incidence of
postoperative arrhythmmias.

A3 can be seen, the results of these

studies are far fron conclusive and further research is needed
before definitive statements can be made regarding the role of
other psychosocial factors in CHD.
Before reviewing studies that examine whether Type As, as
compared to Type Bs, demonstrate reactivity to stressful
situations, an additional issue must be addressed.

This concerns

the question about whether there is a predictive association
between reactivity and CHD development,

predictive associations

have been reported showing that Type A Behavior is predictive of
CHD development.

There are also studies that show, in most cases,

that Type A behavior is associated with degree of atherosclerosis
(Blumenthal, Williams, Kong, Schanberg, & Thompson, 1978; Prank,
Heller, KOmfeld, spom, & Weiss, 1978; Zyzanski, Jenkins, Ryan,
Flessas, & Everist, 1976; Kahn, KOmfeld, Blood, Lynn, Heller, 6
Frank, 1982).

Supportive data is also provided by Friedman,

Roserman, Straus, WUrm, & Kositchek (1968).

These authors

examined the coronary arteries of 51 of the original WCGS
(Roserman et al., 1964) sample who died after the initiation of
the study.

Twenty-five of these subjects died of CHD arid the

remaining 26 subjects died of causes unrelated to CHD.

Twenty-two

of the 25 CHD-related deaths (88 per cent) occurred in subjects
assessed as Type A in the original WCGS.

Further, these authors

t
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found that severe atherosclerosis was six times more likely in
Type A subjects.

However, data regarding whether or not

reactivity itself can predict CHD is lacking.
only able to identify one such study.

This author was

In a 23 year prospective

study. Keys, Taylor, Blackburn, Brozek, Anderson, & Simonson
(1971) examined this issue.

Subjects were 279 upper-class,

employed men, aged 47-57, who were CHD-free at the initiation of
study.

These authors found that the most significant single

predictor of CHD was diastolic blood pressure response to the cold
pressor test.

The hyperreactor group, compared to subjects not

considered to be hyperreactors, was found to have 2.4 times the
risk of CHD death or myocardial infarction. The next best
predictor was a combination of cholesterol level and systolic
blood pressure.

Although the results of one study alone does have

limited generalizability, the work of Keys et al. (1971) provides
intriguing supportive data that reactivity is associated with
disease development.
Returning to the issue at hand, that of how and why Type A
confers coronary risk, one final group of data must be considered.
The collection of studies that follow examined whether or not Type
As, as compared to Type Bs, indeed shew cardiovascular and
endocrine reactivity when exposed to a stressor.

If one is to

accept the tentative hypothesis that reactivity is related to
coronary risk, and that this reactivity operates via synpathetic
adrenal medullary and pituitary-adrenal-cortical axes, then such
reactivity must be demonstrated in a variety of subjects exposed
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to a variety of stressful tasks.

The purpose of the following

discussion is to critically review these studies.
t&unerous studies have been conducted which examine reactivity
in cardiac patients manifesting the Type A behavior pattern.
Aside fran cardiac patients, several other populations have been
used, including college students and healthy adults.

Both

laboratory-induced stressors (e.g., mental arithmetic, reaction
time) and naturalistic settings/stressors (e.g., in the workplace,
coronary artery bypass surgeries) have been used, although the use
of the latter has been far more infrequent.

Type A behavior has

been assessed primarily with the SI and JAS in these studies.
Finally, many different physiologic measures have been assessed.
The diversity of these studies does result in sane degree of
confusion and controversy.

The majority of the studies, however,

demonstrate that Type A persons fail to differ from Type Bs under
conditions of rest, but do tend to differ on sane physiologic
variables when exposed to appropriate stressors.

Studies using

laboratory-induced stressors will be considered first.
Using a reaction-time task, Danbroski, MacDougall, & Shields
(1977) found that Type A college students, assessed by the SI, did
not differ at rest but responded to the BT task with significantly
greater increases in heart rate (HR) and systolic blood pressure
(SBP) when compared to Type B students.
was also observed in the Type A group.
for galvanic skin potential.

Greater HR variability
No differences were found

Jennings (1984) also examined

reactivity using a RT task in healthy students assessed for
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behavior type by both the SI and the JAS.

Si-assessed Overall

Type A was found to be significantly correlated with shorter
vascular transmit times.

Subjects scoring in the Type A direction

of the Speed and Inpatience component of the SI were also found to
exhibit greater task-related HR changes.
during baselines between trials.
revealed for the JAS.

Subjects did not differ

No significant, associatios were

It should be noted that a predictive

association between Type A and CHD has not been shown for the
student form of the JAS (Jenkins et al., 1978).

The results of

these studies suggest that Type As do not differ frcm Type Bs
during periods of rest, there is increased responsiveness to
periods of stresss in Type A subjects.

The work of VanBgeren

(1979) also supports the finding of increased HR to stress among
Type As.

Using a game situation, this author found that healthy

college undergraduates, males and females, assessed by the student
form of the JAS, responded with significantly greater HR
compared to Bs.

as

No significant differences were found for blood

volume pulse or respiration.

Again regarding HR, an interesting

finding was reported by Hart and Jamieson (1983).

They found that

both Type As and Bs, assessed via the JAS-student form, responded
to a perceptual conflict task with increases in HR.

However, they

noted a significantly slower HR recovery after the stressor in
Type As, perhaps suggesting that maladaptively prolonged
cardiovascular arousal might be involved in the mechanisms
underlying Type A and reactivity.
using cardiac patients and normal controls, Dembroski,
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MacDougal & Shields (1977) found that Si-assessed Type A subjects
shewed greater increases in SBP and DBP, compared to controls on
the si and a stressful history quiz, despite the use of
beta-blockers in the cardiac patients.

Corse, Manuck, Cantwell,

Girdani, & Matthews (1982) also made use of a difficult series of
cognitive tasks to study reactivity.

Healthy adult controls and

cardiac patients were assessed for behavior pattern using the JAS
and the SI.

CHD patients were reported to show greater DBP

elevations, compared to controls, independent of behavior type.
Si-determined Type As demonstrated greater increases in SBP and

DBP during the experimental task.

Subjects assesed by the JAS

failed to show significant differences on the physiological
measures.

This latter finding appears perplexing at first glance

because both the SI and the JAS are related to CHD risk.
explanations are possible.

Several

Some researchers would suggest that

the JAS fails to as sensitive as the SI in detecting physiological
differences (Matthews, 1982; Gorse et al., 1985).

It is also

likely that the stressor was not of sufficient severity to induce
greater reactivity in the JAS Type A subjects.

Gorse et al.

(1982) suggested that for laboratory-induced stressors, the use of
the SI may be more appropriate.

Perhaps the use of extreme scores

(ie., less than or greater than one standard deviation from the
mean) for purposes of classification; may have resulted in
different findings.
these issues.
light on this..

Only future research will help to clarify

The work of Williams & Lane (1982) may shed some
These authors used both the SI and the JAS to
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classify subjects (male college students) but only those
classified by both techniques were used in the final sample.

TWO

different tasks— mental arithmetic and reaction time— were used.
Results showed that, during the mental arithmetic task, Type As
showed greater muscle vasodilation, and enhanced secretion of
epinephrine, norepinephrine, and cortisol than did Type Bs.

The

reaction time task was found to be associated with higher levels
of testosterone in Type A subjects.

This well designed study

suggests that physiological differences can be found when using
the JAS.

It also points to the importance of task selection.

Results contradictory to the reactivity hypothesis were
reported by Steptoe & Ross (1981).

Using a series of cognitive

tasks and the JAS student form, they assessed normal volunteers,
and failed to find significant differences on cardiovascular
measures (i.e., interbeat interval, pulse transit time,
respiration, and galvanic skin response).

In fact, Type Bs tended

to show greater reactivity on seme measures.

This study also

%

raises important questions about the appropriateness of the
student form of the JAS.

One should note also that the

physiologic measures chosen have not been demonstrated to
significantly differ in Type As and Bs in other studies.
A few studies using naturalistic settings or real-life
stressors have been published.

Endocrine reactivity (assessed via

urinary epinephrine, norepinephrine, 17-ketoeteroids,
17-hydraxycorticosteroids, and 5-hydroxyindole) was studied by
Friedman, St. George, Byers, and Rosenman (1960).

Si-assessed
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non-CHD male subjects collected urine during four consecutive
workdays and upon awakening for four days.

Results indicated

that, at rest, catecholamine excretion did not differ.

During the

workday, only norepinephrine was found to be significantly related
to Type A behavior.

This study was probably among the first to

demonstrate the lack of difference between As and Bs at rest, a
finding which has been supported by later work.

The lack of

experimental control over the work situation and failure to
measure workday stress are two inportant flaws in this study, and
which are, perhaps, responsible for the lack of significance found
on other variables.
The role of ACTH and cortisol was examined by Friedman,
Roserman, and St. George (1969) and Friedman, Byers, and Rosenman
(1972).

Following the injection of 100 units of ACTH (reported to

be twice the amount needed to effect a maximal cortisol
discharge), three urine samples were obtained (one inmediately
prior to injection, and one at 14 and 19 hours post-injection) so
that analysis of 17-hydroxycorticosteroid (17-OHCS, a metabolite
of cortisol and other adrenocortical glucocorticoid hormones)
could be conducted.

Subjects were 18 Type A and 20 Type B

assessed by the early version of the SI.

Results revealed no

significant differences between basal levels of 17-OHCS.
hours, considerable differences were found.

At 19

Type As were found to

have excreted abnormally low levels of 17-OHCS as ccnpared to Bs.
The hypo-respose of the Type As was perplexing.

Friedman et al.

(1969) postulated that this loss of "adrenal reserve" could be due
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to a previous long standing or excessive discharge of ACTH.

The

authors suggested that future research, comparing ACTH levels in
Type A and B subjects was necessary before conclusions could be
drawn.

As a follow up study, Friedman et al. (1972) measured

plasma ACTH, plasma cortisol, and plasma cholesterol
concentrations during five intervals of the working day in 9 Type
A and 10 Type B subjects.

With in-group and between-group cortisol

and ACTH varied considerably and resulted in failure to find
significant differences.

Despite this, however, the authors noted

that average ACTH values of Type A subjects was greater than those
of Type B subjects at each of the six sampling intervals.
Friedman et al. (1972) determined that there was a very low
probability of observing these differences across all sampling
intervals.

They concluded from this that Type A subjects

exhibited an increase in ACTH as compared to Type B subjects.
Significance was found for the occurrence of greater peak values
of ACTH in Type As.
cortisol.

No significant differences were found for

As expected from their previous research, plasma

cholesterol was significantly greater in Type As.

Friedman et al.

(1972) concluded that this hypersecretion of ACTH suggested that
there were alterations in the hypothalamo-pituitary-adrenal
systems of these Type A subjects.

Despite obviously problematic

methodology (i.e., small sample size, lack of experimental
control), significant differences were found for ACTH, attesting,
perhaps, to the robustness of this measure.

However, the

weaknesses in the study suggest that the results should be
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interpreted with caution.

Further research is necessary before

definitive statements can be made.

It is interesting to note that

such research remains to be conducted.
A study conducted by Czeisler (1976) may help to shed sane
light on the difficulties inherent in utilizing endocrine
responses as measures of reactivity.

Four coronary patients

awaiting open heart surgery and five healthy volunteers
(hospitalized for purposes of the study) served as subjects.
Czeisler (1976) collected plasma cortisol samples every 20 minutes
for the 24 hours prior to the experimental groups' scheduled
surgery.

Anxiety was rated by each subject on a five point scale

during each of these intervals.

Indistinguishable and normal

patterns of cortisol secretion were found for both the control and
experimental groups across all sampling intervals with only one
exception.

During preoperative preparation for surgery (i.e.,
i

shavingr antiseptic wash, and enema), experimental subjects had
3.7 times higher cortisol concentrations than did controls ( £ <
.001).

in fact, cortisol in experimental subjects increased seven

to 10 standard deviationsfran the control group mean obtained at
the same time.

No significant correlations were obtained between

anxiety ratings and cortisol concentrations.

These authors

concluded that the experience of he pre-surgery situation alone
did not result in hyperactivation of the pituitary-adrenal axis.
Based on the results of cortisol secretion during preoperative
preparation, Czeisler (1976) noted that, although cortisol is
generated endogenously, it can be influenced by stress.

Furthur,
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frequent blood sampling was recommended by these authors because
failing to do so in this study would probably have resulted in
overlooking the significant data.

Although the study reported by

Czeisler (1976) did not address Type A reactivity, it does
illustrate the level of complexity involved in psychoendocrine
research.
A few other naturalistic studies are available in the current
literature (Kahn, KOmfeld, Frank, Heller, 6 Hoar, 1980; Krantz,
Arabian, Davia, & Parker, 1982; KOmfeld, Kahn, Frank, Heller,
Freeman, & Keller-Epstein, 1985).

All three of these studies

address hemodynamic reactivity in patients undergoing coronary
artery bypass grafting (CABG). Kahn et al. (1980) examined
intraoperative blood pressure in 59 cardiac patients, assessed for
behavior type using the SI.

Blood pressure values were obtained

by subtracting admission blood pressure (BP) from maximum
intraoperative BP values.

Results revealed significant

correlations between SBP rise and the SI components of Overall
Type A, Aggressive Content, and Job Commitment.

Diastolic blood

pressure and Job Commitment were also found to be correlated.
These associations remained significant even when physical
predictors of blood pressure rise were controlled.

It is notable

that significant hyperreactivity among Type A subjects was
demonstrated despite patients being under general anesthesia.
These findings were supported by Krantz et al. (1982).

Using both

SI- and JAB-determined Type A and B cardiac patients undergoing
CABG, Krantz et al. (1982) found that, after controlling for
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physical predictors of blood pressure riser Type A (SI assessed
only) was significantly related to SBP increases during surgery.
Correlations with the JAS scales were smaller and unreliable.

In

addition, these authors reported a larger incidence of surgical
complications (i.e., arrhythmias) in si-assessed Type As. The JAS
also failed to correlate with surgical complications,

one should

note, however, that the JAS analysis was conducted with an even
smaller sample size (N * 21) than was originally used (N 3 27).
The results of Krantz et al. (1982) are consistent with previous
research suggesting that conscious mediation is not necessary for
Type A reactivity to occur.

Disconfirming evidence was reported

by Romfeld et al. (1985), although non-cardiac patients
undergoing general elective surgery served as subjects.

Kornfeld

et al. (1985) failed to find significant associations between
Si-assessed Type A and intraoperative hemodynamic changes.

A

trend was noted for Overall Type A score and DBP at baseline and
intraoperatively.
The importance of controlling for medications when studying
cardiac patients has been demonstrated by several studies.
Anxiety, at least in part, results from beta-adrenergic
stimulation, and, therefore, drugs which reduce or block this
response (i.e., beta-antagonistic drugs such as propanolol) would
be expected to influence the hemodynamic and endocrine response to
a stressful situation, particularly in subjects with somatic
manifestations of anxiety.

Beta-blockers are said to exert their

greatest influence when sympathetic nervous system activity is
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intense (Durel et al., 1985) suggesting the need for control when
examining the stress response in cardiac patients. The early work
of Granvi1le-Grossman and Turner (1966) provided the first
evidence that the use of propanolol was associated with a decrease
in investigator-rated and personal symptom ratings of anxiety.
Since this time, a number of studies have been conducted with
beta-blocker treated cardiac patients under stress.

A variety of

different stressors have been used and results have not been
conclusive.

Seme cannon results can be found across studies.

Using normals and hypertensives exposed to a reaction time task,
Heidbreder, Rockel, & Heidland (1978) found no effects of
beta-blockade for HR.

Different results were obtained by Bonelli,

Hortnagl, Maganetschnigg, Lochs, & Kaik (1979).

These authors

found a significant association between HR decrease and
beta-blockade in normal volunteers' response to calculation
stress.

No effects were found for BP, E, or NE, although a very

small sample size (N ■ 6) was used.

Neftel, Adler, Kappeli,

Rossi, Dolder, Kaiser, Bruggesser, & Vorkauf (1982) supported the
findings from previous research that HR and beta-blockade were
significantly related.
catecholamines.

However, again, no effect was found for

Bonelli (1978) also found significantly reduced

HR, as well as cardiac output, SBP and DBP reduced by
beta-blockade.

Bonelli (1978) also failed to find that

beta-blockade significantly altered catecholamine response.

One

study that specifically addressed the association between Type A
and beta-blockade was conducted by Krantz, Durel, Davia, Schaffer,
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Arabian, Dembroski, 6 Macdcogall (1982).

Using a stressful

interview and a history quiz, these authors found that propanolol
treated patients showed less Si-assessed Type A characteristics,
lesser HR, and lesser rate-pressure products, a correlate of
myocardial oxygen supply.

These effects were not found in

patients being treated with nitrates, central nervous system
drugs, or diuretics.
BP.

No significant differences were found for

The JAS-assessed Type A behavior was not related to

medication.
Although definite conclusions cannot be drawn fran these
studies, the evidence, in general, appears to support the notion
that beta-blockade is useful in reducing seme physiologic
manifestations of anxiety (Durel et al., 1985).
consistent effects appear to be on HR.

The most

There is still

considerable controversy regarding BP and catecholamine response
to stress and beta-blockade. A particular problem area appears to
be the use of small sample sizes.
Several investigators have also examined the effects of
calcium antagonists on physiologic reactivity (Corea, Miele,
Bentivoglio, Boschetti, Agabiti-Rodei, & Muisesan, 1979; Taylor,
Silke, Ahuja, & Lkoli, 1982; Heidbreder, Schafferhans, Kirsten, &
Heidland, 1983; Pederson & Mikkelsen, 1978).

Pederson and

Mikkelsen (1978) reported significant decreases in HR and vascular
resistance, and a significant increase in forearm blood flow, with
acute administration of nifedipine in hypertensive patients.
Corea et al. (1979) found a sustained decrease in BP (without HR
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increase) in hypertensives.

In normals, a significant increase in

HR was found without any change in HP.

In response to three

different pressor stimuli, Taylor et al. (1982) documented a
significant dose-related reduction in BP in six male
hypertensives.

Heidbreder et al. (1983) examined the physiologic

response (via BP, HR, and catecholamines) to a mental stressor in
normal persons taking either a calcium antagonist, nifedipine, or
a diuretic, hydrochlorothiazide. The purpose of this study was to
determine whether drugs with a hypotensive effect, but without
sympatholytic properties, would result in the suppression of an
emotional response to a stressor.

The results of the study did

not support this hypothesis and the authors concluded that neither
drug inhibited emotional stress in normotensive subjects.

Hie

results of these studies are also controversial as are those
investigating the effect of beta-blockade.

Future reactivity

research, controlling for the effect of medications, may shed seme
light on this confusion..
As can be seen frcm the foregoing review, findings within the
area of Type and reactivity are not unequivocal.

Although the

greater majority of studies do shew that Type As appear to be more
reactive to stress than Type Bs, it is still a matter of
speculation whether reactivity confers risk,

it may also be

obvious to the reader that several variables appear to influence
reactivity.

To summarize, characteristics of baseline, task

(stressor), subject, and response measure assume critical
importance.

According to Houston and Ewart (1984), tasks that
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provide a challenge, ccnpetition, or threat, have most often
resulted in reactivity in Type A subjects.

The use of such a wide

variety of these parameters has resulted in same degree of
confusion in the Type A literature.

Future research aimed at

isolating the important dimensions of these parameters is needed.
Surrmary
The Type a Behavior pattern, originally described by
cardiologists Friedman & Rosenman (1959), is best characterized as
a set of overt behaviors which can be elicited fran a susceptible
individual given an appropriately challenging environment
(Matthews, 1982).

The central elements of the behavior pattern

appear to be a sense of time urgency, easily aroused hostility,
and competitive achievement striving.

Epidemiological studies,

notably those of Rosenman et al. (1964, 1975) and Haynes et al.
(1978, 1980), have shown that the Type A Behavior Pattern is
significantly associated with an increased incidence of coronary
heart disease, even when traditional risk factors are controlled.
In 1981, the Review Panel on Coronary-Prone Behavior and Coronary
Heart Disease concluded that Type A behavior is an independent
risk factor for clinically apparent coronary heart disease and
that the magnitude of risk associated with this behavior pattern
is as great as those imposed by traditional risk factors such as
elevated systolic blood pressure, smoking, and serum cholesterol.
As evidence began to accumulate in the area of Type A
research, same authors began to speculate that psychophysiologic
responsiveness (i.e., reactivity) could be a marker in the
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development of cardiovascular disease (see reveiw by Krantz et
al., 1984).

it was hypothesized that pathologic neuroendocrine

and cardiovascular responses could link psychosocial stress to
cardiovascular disease.

A great deal of attention was then

focused on the roles of the sympathetic adrenal-medullary system
and the pituitary adreno-cortical system.
A variety of stressors have been used in the study of
reactivity, including both laboratory (e.g., mental arithmetic,
reaction time, cold pressor) and naturalistic (e.g., cardiac
catheterizations, treadmill tests, and coronary bypass surgeries)
settings.

There is a substantial body of data to show that Type

As and Bs fail to differ under conditions of rest.

Under stress,

however. Type As almost consistently shew differences, as compared
to Type Bs, on at least one of the neuroendocrine and/or
cardiovascular measures under study,

under conditions of stress.

Type As, as compared to Type Bs, tend to show larger episodic
increases in blood pressure, heart rate, catecholamines, ACTH, and
cortisol.

It is noteworthy that larger differences are often

found when real-life stressors are used, attesting to the
importance of task selection in this area of study.
Several shortcomings within the area of reactivity were noted
in the foregoing review.

First, although a great deal of research

has assessed the catecholamine (e.g., norepinephrine, epinephrine)
response to stress, little attention has been paid to the release
of adrenocorticotropic hormone (ACTH) in response to stress.

Only

two studies, published in the late 1960s and early 1970s, were
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found in the literature.

In comparison to studies that examined

catecholamines and cortisol, these two ACTH studies reflect a
deficit in the area.

Further, recall that pituitary ACTH cannot

be assumed from measures of cortisol concentration (Krieger,
1979).

It would appear then that little is known about ACTH

reactivity in Type A subjects.

This represents a major gap in the

literature, particularly in light of the importance of ACTH in the
stress response.

ACTH is a well documented indicator of stress

(Axelrod, 1984) and the present study utilizes this measure as a
physiological dependent variable,

second, the use of laboratory

stressors dominates the area and several researchers have
suggested the need for more naturalistic studies (Krantz et al.,
1984).

Further, the JAS has been infrequently used, or has been

used with small samples, such that less is known about
JAS-assessed Type A responses to a challenge or stressor.

The

objectivity of the JAS, as well as sane practical considerations,
suggests that its use in Type A assessment will continue so that
the importance of establishing its parameters is necessary.

The

present study compares the responses of JAS-assessed Type As and
Bs to a real-life cardiac catheterization.

Finally, until

recently there has not been adequate attention placed on the
importance of medications and how they might alter the stress
response.

Existing research has thus far been inconclusive.

Because of a number of practical problems, the most important of
which was sample sizes, it was not possible in the present study
to form different drugs groups.

The next best approach, that of
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comparing patients on target medications (i.e., beta-blockers,
calcium-channel blockers or both of these) to those that were not
on target medications, was used.

In addition to the advantage of

controlling these variables, the present study also attempted to
investigate the effects of these medications on the response to
stress.
Purpose of the Present Study
The purpose of the present study was to investigate hew
cardiac patients, identified as manifesting Type A or Type B
Behavior Patterns, would respond to the stress of cardiac
catheterization.

The primary reseach question being asked was

whether the Type a cardiac patients would show an increased
physiological and psychological reactivity (i.e., exaggerated
response) to the stressor.

Limited ACTH research thus far would

suggest that Type A individuals are indeed more reactive to stress
than their counterparts, the Type B individual.

However,

published findings (Friedman et al., 1969, 1972) have been few and
not without controversy.

One of the important aims of the present

study, therefore, was to aid in the clarification of this
phenomenon, particularly with respect to the role of ACTH in the
response to stress.

Another important research question addressed

in the present study was that of how medications might influence
or alter the response to a stressor.
divided into two medication groups.

Patients in the study were
Patients taking beta

adrenergic blockers, calcium entry blockers, or both of these
drugs formed the drug condition of the independent variable of
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Drug Group.

Patients not taking any of these medications formed

the no drug condition of Drug Group.
Based on the findings fran previous research, several
hypotheses were formulated.
1.

All subjects are expected to show some degree of hormonal

(i.e., ACTH) and cardiovascular (i.e., HR and BP) responsivity to
the stress of cardiac catheterization.

Although individual

differences will exist, there is substantial data to suggest that
exposure to stress results in the mobilization of the
synpathetic-adrenal-medullary system and the
pituitary-adrenal-cortical system (Axelrod et a., 1984).

This is

said to be particularly true when a stressor has an element of
uncertainty or unpredictability (Mason, 1968) or when it results
in fear and anxiety (Selye, 1950).

The cardiac catheterization

can be said to possess many of these elements, and therefore,
aside fran individual differences that might exist, a general
response to stress can be expected across all subjects.
2.

ttamerous studies previously reviewed (e.g., Krantz et

al., 1982; Eliot, 1982) suggest that Type A individuals, in
comparison to Type Bs, tend to shew exaggerated responsivity
(i.e., reactivity) to stressful situations.

Although sane

discamfinning evidence has been reported, Type A subjects have
been shown to respond to stress with greater elevations in HR and
BP (Dembroski et al., 1977; VanEgeren, 1979; Hart et al., 1983;
Corse et al., 1982; and Kahn et al., 1980) and ACTH (Friedman et
al., 1969,1972).

Therefore, Type A subjects in the present study
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are expected to shew greater hormonal and cardiovascular
reactivity than Type B subjects.
3.

Drug Group (i.e., drug versus no do drug) is also

expected to influence reactivity to stress.

Although again

research in this area has not.been without controversy, the
findings reported by Bonelli (1978, 1979) and Krantz et al. (1982)
suggest that beta-blockade (i.e., treatment with beta-adrenergic
blocking drugs) is useful in reducing physiologic manifestations
of anxiety.

Durel et al. (1985) note that the most consistent

finding is that of HR reduction.

With respect to calcium-channel
*

blockers, evidence is even more sparse and equally conflictual.
Several researchers (Pederson et al., 1978; Corea et'al., 1982;
Taylor et al., 1982) have reported that reductions in HR and BP
occur in patients treated with calc ium-channel blockers.
Conversely, Heidbreder et al. (1983) reported that treatment with
these drugs does not suppress the emotional response to a
stressor.

No data appear to be available with regard to the

combined treatment of both beta-blockers and calc ium-channel
blockers.

However, clinical observation (Usher, 1985) suggests

that the effect of the beta-blocker will "override" the effect of
the calc ium-channel blocker.

Therefore, the predicted primary

effect of the Drug Group is that of beta-blockade and
consequential stress reduction. Subjects in the No Drug condition
are expected to show the greatest response to the stressor.

The

hypothesis related to the influence of drug group upon Behaior
Type is illustrated as follows:

Type A (neither drug) > Type A
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(drug) > Type B (neither drug) > Type B (drug).
4.

Regarding psychological measures (i.e., anxiety and mood

scales), similar events are hypothesized.

Following the logic

proposed in the preceding hypotheses, all subjects are expected to
show seme degree of psychologic responsivity.

Type A subjects, as

compared to Type B subjects, are expected to demonstrate
exaggerated responsiveness and medications are expected to
influence this response.

That is, patients in the Drug Group are

expected to report less anxiety and mood disturbance because of
the perception of less somatic manifestation of anxiety produced
by these drugs.

Further, subjects showing elevated trait anxiety

scores are predicted to demonstrate greater psychologiceil and
physiological responsiveness.

i

CHAPTER TOD
Method
Subjects
Sixty-three patients of the Medical University Hospital in
Charleston, SC, referred for cardiac catheterization frcm
November-June, 1986, served as subjects in the present study.
Partial data was also collected on an additional 21 subjects that
could not be included in data analysis.

Eleven of these 21

subjects were not available for post-catheterization follow-up
because of other scheduled diagnostic tests or because of the
necessity for emergency surgery.

Approximately six subjects were

lost because of experimenter error.

An additional two subjects

were excluded because of conditions unknown to the experimenter at
the time of data collection (i.e., pacemaker and dialysis
patient).

One subject was excluded because of an invalid JAS

(i.e., greater than six items unanswered).
not undergo scheduled catheterization.
the study were:

(a)

Another subject did

Criteria for inclusion in

English-speaking white males between the

ages of 25 and 70 referred for diagnostic workup for symptoms of
coronary heart disease (eg., angina, myocardial infarction); (b)
consent of primary physician; and (c)
in the study.
(a)

willingness to participate

Patients were excluded from the study if they had

previous coronary surgery; (b)

diseases known to affect ACTH

production (e.g., Cushing's disease); (c)

cardiovascular

physiology was controlled by artificial means (e.g., pacemaker),
or (d)

if they were taking long term psychotropic medications.
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Independent variables
The Type A Behavior Pattern was assessed using the Jenkins
Activity Survey-Form C (JAS, Jenkins et al., 1979).

The JAS was

computer scored and standard and percentile scores were obtained
to yield an Overall Type A score and three factor scores—

Speed

and Inpatience, Job Involvement, and Hard-Driving and Competitive.
Subjects were designated as Type A or Type B according to a median
split using the Overall Type A standard score.. That is, subjects
scoring in the positive direction (i.e., greater than the mean of
0.00) were identified as Type A subjects.

Type B subjects were

those with Overall Type A scores in the negative direction (i.e.,
less than the mean of 0.00).
Subjects were also be grouped according to what type of
medication they were taking for their coronary synptans.

within

each of the two behavior groups (A or B), two medication groups
were formed:

(a)

patients taking beta-adrenergic blocking agents

(e.g., propanolol), calcium entry blocking agents (e.g.,
nifidipine, and patients taking both of these drugs; and (b)
patients taking neither of these two drugs.
Dependent Variables:

Physiological

All dependent measures were obtained on each of two occasions
for each subject— approximately one hour prior to catheterization
(stress condition) and the morning after the catheterization
(non-stress condition), 24 hours after pre-catheterization
measures were obtained.
The major dependent variable assessed in the study was level
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of plasma adrenocorticotropic hormone (ACTH). Two fasting blood
samples were obtained as described above.

ACTH samples were

analyzed using Nichols Institute Diagnostics commercial ACTH
radioimmunoassay (RIA) kits.

For the present experiment/ 10.0

milliliters of venous blood was collected in siliconized glass
tubes, with EDTA added as a anticoagulant/ on each of two
occasions (i.e., pre- and post-catheterization).

To prevent

enzyme degradation, blood samples were kept on ice until
centrifuged and frozen.

Plasma was separated after samples had

been centrifuged at 2200 x gravity, 4 degrees centigrade for 15
minutes and at 7500 x gravity, 4 degrees centigrade, for 10
minutes.

Plasma samples were stored at -80 degrees centigrade

until assay.
The radioimmunoassay procedure is based upon the principles
of competitive binding established by Berson et al. (1968).

The

basic principle involves the measurement of unlabeled ACTH (i.e.,
unknown sample) by its ability to compete with radiolabeled ACTH
for specific antibody binding sites.

Known concentrations of ACTH

(i.e., standard samples provided in the kit) are used to establish
a dose-response curve.

Patient samples are then evaluated by

comparison with this curve.

As concentrations of unlabeled ACTH

increase, the amount of radiolabeled ACIH bound to antibody
decreases proportionately.

In a sample of 278 healthy adults,

Nichols Institute (kit manufacturer) reported the normal range of
ACTH to be less than 130 pg/ml.

Normal values are also routinely

established by each laboratory as one of the many accuracy checks
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involved in the RIA.

Using 13 healthy adults, the present

investigator found that all values were belcw 130 pg/tnl ( M = 42
pg/inl,

SD » 37.00).

The instructions for the radioimmunoassay were followed
exactly with the exception of an addition of two other standard
samples.

All samples were assayed in duplicate and pre and post

samples for each patient were analyzed in the same assay.

All

samples were counted in a Model 1282 Ganmacounter (Wallace
Instruments, Inc.).

Samples with counts per minute exceeding

that of the maximum binding tube were incalculable and were
excluded frcm the analysis ( £ = 12).

Therefore, only 48 ACTH

samples on each Day 1 and Day 2 are included in ACTH analyses.

It

is not known what produced the enhanced binding in these subjects.
Reliability of plasma ACTH radioimmunoassays has been
reported by Berson et al. (1968).

When duplicate samples are

assayed during the same procedure, levels of agreement have been
reported to be excellent.

Somewhat less agreement has been

observed when duplicate samples are assayed in two different
procedures.

In the present study, duplicate samples were analyzed

in the same assay.
In order to assess group differences in level of arousal,
other physiologic measures reflecting anticipatory anxiety were
obtained.

These were blood pressure (as measured by

sphygmcmancmetry) and heart rate (as measured using radial pulse)
obtained once under both conditions of stress and non-stress as
described above.

For each subject, each of these measurements was
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taken using the same a m and with the patient in the same physical
position (i.e., lying in bed).
Dependent Variablest

Psychological

TWo psychological measures were used to assess subjects level
of perceived stress.

The State-Trait Anxiety Inventory-Form X

(STAI, Spielberger, Gorsuch, & Levine, 1970) and the Profile of
Mood States (PCMS, McNair, Lorr, & Droppleman, 1971) were
administered to all subjects under both conditions of stress and
non-stress.

The State portion of the STAI and the POMS were used

to assess current level of arousal.

The Trait portion of the STAI

was used in order to investigate associations between
self-reported trait anxiety and measures of reactivity.
The STAI is composed of two separate self-report scales for
measuring state anxiety (A-State) and trait anxiety (A-Trait).
The A-State portion of the inventory contains 20 statements to
which the subject is instructed to respond according to how he or
she feels at that particular moment.

The A-Trait portion is

similar, however, the subject is instructed to respond according
to how he or she generally feels.

A four-point scale

(not at

all, somewhat, moderately so, and very much so) is used on both
inventories. Test-retest reliability for the A-Trait has been
found to range from .73 to .86.

A-State test-retest reliability

is much lower (i.e., .16 to .54) as would be expected since moment
to mcment anxiety levels are likely to fluctuate.

Internal

consistency has also been demonstrated with reliability
coefficients ranging from .83 to .92.

Construct and concurrent
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validity have also been demonstrated (see Spielberger et al.,
1970).
The FCMS is a 65-item adjective rating scale in which the
subject is instructed to use a five-point scale to indicate how he
or she has been feeling during the past

(time set).

For

purposes of the present study, a time set of Right Now was used.
The five-point rating scale is composed of:
moderately, quite a bit, and extremely.
derived:

(a)

Tension-Anxiety, (b)

Anger-Hostility,

(d)

not at all, a little,

Six factor scores are

Depression-Dejection, (c)

Vigor-Astivity, (e)

Fatigue-Inertia, and

*

(f) Confusion-Bewilderment. A Total Mood Disturbance (TOD) score
was computed by summing all scores except Vigor-Activity. This
latter factor score was subtracted from the sum of the other
factor scores resulting in the TOD score.
used in the present analyses.

Only the TOD score was

For a more thorough description of

these factor scores, the reader is referred to McNair et al.
(1971).

Both the rest-retest reliability (ranging frcm .61 to

.69) and internal consistency (.90 and above) estimates have been
highly satisfactory. Evidence for the predictive and construct
validity of this self-report instrument has been demonstrated in
brief psychotherapy studies and controlled outpatient drug trials.
Procedure
Patients scheduled for cardiac catheterization are usually
hospitalized for 36-48 hours.

Prior to hospital admission, all

patients were provided with an information booklet (Purcell, 1982)
which described the catheterizaton procedure in simple terms.
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Following admission, potential subjects were recruited by the
principal investigator.

Patients were told that the present study

was designed to investigate how different individuals responded to
the stress of cardiac catheterization.

After signing an approved

informed consent agreement (see Appendix A), subjects completed a
Personal Information Form (see Appendix B) which requested
demographic information (age, education, occupation) and
information regarding traditional risk factors (e.g., family
history of cardiovascular disease, smoking history, etc.). The JAS
and the Trait portion of the STAI were also completed at this
time.

Subjects were also seen on this day by the attending

cardiologist or the Cardiology Fellow in order to answer any
remaining questions that the subject (patient) may have had
regarding the cardiac catheterization.
'On the morning of the procedure, prior to sedation with an
oral dose of secobarbitol lOOmg, vital signs (BP and HR) and blood
samples were obtained by a registered nurse on the unit.

The STAI

and the PGMS were completed by the subjects at this time.

These

measures were obtained, as closely as possible, at approximately
one hour prior to scheduled time of catheterization.

Delays

and/or changes in expected time of catheterization did occur due
to procedures followed by the catheterizaton team.

However, once

measures were collected, these subjects were included in the data
analysis unless they became unavailable for post-catheterization
data collection procedures (e.g., next day emergency surgery).
No attempt was made to assess fear of the blood-drawing procedure.
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However, a number of patients refused to participate in the
present study stating this fear as the primary reason for
nonccmpliance with the study.
All catheterizations were performed by the Fellow in
Cardiology under the supervision of the attending cardiologist.
Standard clinical cardiac catheterizations were done.
Catheterizations for subjects in the present study were limited to
those scheduled between the hours of 7:00 a.m. and 12:00 p.m.
Catheterizations were conducted Monday through Friday.

All

patients were again seen by their physician on the evening of the
catheterization for a report of preliminary findings and
recommendations.

It was impossible to alter this routine without

disrupting the standard procedure followed by the catheterization
team.

Therefore, this information was taken into account in the

statistical analyses.
On the day after the catheterization, 24 hours after
dependent measures were obtained the previous day, fasting blood
samples and vital signs were obtained and the STAI and the FCMS
were again completed.
Each subject's medical chart was also reviewed in order to
obtain information on traditional cardiovascular risk factors,
medications, and catheterization results and recommendations.
Catheterization recommendations
necessary, (b)

were recorded as (a)

medication only, and (c)

surgery

other. The category of

other was used to indicate a more general recaronendation of
further procedures (i.e., coronary angioplasty or a trial of
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medication followed by surgery if unsucessful).
Upon completion of data collection, subjects were debriefed
and thanked for their participation.
Experimental Design and statistical Analysis
A 2 x 2 x 2 (Behavior Pattern x Drug Group x Day) mixed
effects design was employed,

two

levels of behavior pattern (Type

A or Type B) and two levels of drug group (drug and no drug) were
used.

Day served as the repeated factor.

of day:
2).

There were two levels

pre-catheterization (Day 1) and post-catheterization (Day

Day 2 was conceptualized as the best available assessment of

baseline functioning.

Initially, the study was designed to

investigate four drug groups:

beta-blockers, calcium channel

blockers, a combination of both of these, and a group of subjects
who did not take either of these two medications.

Due to small

sample sizes, in general, and the loss of 12 ACTH samples, in
particular, it was deemed that the use of four drug groups would
be impractical.

Therefore., drug groups were collapsed to form

two levels of the independent variable of drug group.

The drug

condition (level) was composed of patients taking beta-blockers,
calcium-channel blockers, or a combination of these.

The no drug

condition was comprised of patients taking neither of these two
drugs.

CHAPTER THREE
Results
A total of 63 subjects were available for analysis.

After

means and standard deviations were calculated, an analysis of
outliers was conducted.

A total of 15 subjects were found to fall

at least two standard deviations from the mean on at least one
dependent variable.

Removal of 15 subjects was deemed to be

impractical as it would have greatly reduced sample size to
unacceptable levels.

Therefore# only those subjects with scores

of at least three standard deviations from a mean of a particular
dependent variable mean were excluded. Outliers on any one
dependent variable were excluded from all analyses.
subjects were excluded# the final sanple was 60.

After three

Statistical

analyses were conducted on the full sanple ( N - 60) and an a
subsample of this population referred to as the extreme sanple ( N
“ 30).

The extreme sanple was canpoeed of subjects from the full

sanple who scored in the upper (i.e.# extreme Type A) and lower
(i.e.# extreme Type B) quartiles on the Overall Type A scale of
the JAS.
Full Sanple
Subjects ranged in age from 37 to 69 years ( M - 53.45#
9.68# N « 60).
1.

SD -

Additional demographic data is presented in Table

Twenty-eight Type As and 32 Type Bs ware identified.

Means

and standard deviations for the four JAS scales are presented in
Table 2.
Chi-square analysis revealed no significant differences

Table 1
Demographic Characteristics of Sample (N- 60)
Variable

Per Cent

Education
< 12 years

23.0

high school

25.0

some college

20.0

college degree

32.0

Employment
full-time

56.0

part-time

3.0

unemployed

2.0

retired

38.0

History of Myocardial Infarct

48.0

Family History of CHD

58.0

Hypertension

35.0

Diabetes

15.0

Hyperllpldemia

10.0

69
Table 2
Mean Standard Scores of Jenkins Activity Survey (JAS) Factors for
Type A (n»28) and Type B (n=32) Subjects

JAS

Type A

Overall Type A

Speed & Impatience

Job Involvement

Hard-Driving & Competitive

Type B

M =

9.30

M a

-8.37

SD a

6.25

SD =

3.96

M =

6.16

M =

6.82

SD =

6.57

SD a

8.85

M =

-1.24

SD a 11.25

SD a

M a

M a

4.50

SD a 10.06

Note.

M a

-9.85
8.11
-0.91

SD a 10.80

The JAS factors are scored such that the normative means

are 0.00 and the standard deviations are 10.00.
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between behavior type or drug group for age, education,
occupational status, history of myocardial infarction, family
history of CHD, diabetes, hyperlipidemia, or cigarette smoking.
Presence or absence of hypertension was found to be significant
for drug group, X

(3, N » 60) * 9.06,

£

< .03.

A one-way ANOVA was also conducted for catheterization
recommendations (i.e., surgery, medication, other) to examine
whether knowledge of recommendations influenced the dependent
variables obtained on day 2.

No significant differences were

found.
A 2 x 2 x 2 (Behavior Type x Drug Group x Day) analysis of
variance (ANOVA) with repeated measures on day was performed for
all dependent variables using both the full sanple ( N
the extreme sanple ( N

- 30).

>60) and

Dependent variables were

adrenocorticotropic hormone (ACTH), systolic blood pressure (SBP),
diastolic blood pressure (EBP), state anxiety, and total mood
disturbance (TMD).

statistical summary tables for the full sanple

are presented in Appendix C.

Statistical summary tables for the

extreme sanple are presented in Appendix D.
Using the full sanple, a significant main effect for Day was
revealed for ACTH, F (1, 44) * 6.38, £ < .01.

Mean ACTH

concentrations for day 1 (pre-catheterization day) and day 2
(post-catheterization day) were 43.17 pg/faL (picograms per
milliter of plasma) and 34.57 pg/ml, respectively.

A significant

main effect for drug group was also revealed for ACTH, F (1, 44) ■
4.42, £ < .04.

Subjects in the drug condition exhibited a mean
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ACTH level of 35.33 as compared to a mean of 47.48 for subjects in
the no drug condition.

A significant Type x Drug interaction was

found for ACTH. F (1, 44) - 9.63. £ < .003.

The interaction is

illustrated graphically-in Figure 1.

Relevant means and standard

deviations are presented in Table 3.

Inspection of Figure 1

reveals that Type B subjects did not differ regardless of drug
condition,

in contrast. Type A subjects exhibited substantially

larger ACTH concentrations in the no drug condition as compared to
the drug condition.

Further. Type A subjects on no drugs

exhibited much larger responses to the stressor than did Type B
subjects on no drugs.
In terms of the full sanple. a main effect for Day was found
for SBP. F (1. 56) ■ 4.51. £ < .04.

Systolic blood pressure on

day 1 was 122.78 itmHg (millimeters of mercury) as compared to
118.68 mmHg for subjects on day 2.

A Type x Day interaction was

also revealed for SBP. F (1, 56) = 6.39. £ < .01.
is graphically illustrated in Figure 2.

The interaction

Means and standard

deviations for this interaction are presented in Table 4.
Inspection of Figure 2 reveals that SBP for Type As and Type Bs
did not differ on day 1.

In contrast, Type As demonstrated

substantially lower levels of SBP, as compared to Type Bs, on day

2.
No significant main effects or interactions were revealed for
C6P. HR, or TMD.

The only effect revealed for state anxiety was a

main effect for day, F (1, 56) ■ 3.97, £ < .05.

This main effect

for day reflected a significant difference between 36.02 for day 1

CM

I"

ACTH Concentration (pg/ml)

Figure 1. Means ofACTH Collapsed across Days by Drug Group
ForType A and Type B Subjects {a=48)
70 _
60.
50.
TypeB
Type A

10.

No Drug

Drug

Drug Group
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Table 3
ACTH Means and Standard Deviations for Type x Drug x Day
(N - 48)

n

ZEE®

Drug

M

SD

6

A

no drug

1

77.87

34.40

6

A

no drug

2

54.14

31.01

16

A

drug

1

34.33

21.41

16

A

drug

2

25.18

13.50

8

B

no drug

1

34.38

12.08

8

B

no drug

2

32.78

17.68

18

B

drug

1

43.37

33.10

18

B

drug

2

37.20

27.34

r-

Figure 2.
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Table 4
SBP Means and Standard Deviations for Type x Drug x Day
( N - 60)

ja

Type

Drug

Day

M

SD

8

A

no drug

1

128.62

32.71

8

A

no drug

2

112.25

10.71

20

A

drug

1

121.25

16.94

20

A

drug

2

115.50

13.84

10

B

no drug

1

121.20

16.73

10

B

no drug

2

124.80

21.56

22

B

drug

1

122.77

15.50

22

B

drug

2

121.14

12.19
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and 33.93 for day 2.

Means and standard deviations for State

Anxiety, EBP, HR, and TWD are presented in tables 5/ 6, 7, and 8,
respectively.
Extreme Sample
A 2 x 2 (Behavior Type x Day) ANOVA with repeated measures on
day was conducted for the extreme sample ( N ■ 30).

No main

effects for type or Type x Day interactions were revealed for any
of the dependent variables.

Two significant main effects for day

were found for HR, F (1, 28) =■ 4.30, £ < .05, and for state
anxiety, F (1, 28) * 4.07, £ < .05.

The means for HR for this

extreme sample were 68.40 and 71.07 for day 1 and day 2,
respectively.

For state anxiety, the main effect for day

represents a significant difference of 36.23 for day 1 and 33.03
for day 2.
Correlational Data
Pearson correlations were obtained among all dependent
variables.

The correlation matrix is presented in Table 9.

For

purposes of clarity of presentation, dependent measures will be
classified as (a)

biochemical, including ACTH; (b)

cardiovascular, including SBP, DBP, and HR; or (c)
or self-report, including State Anxiety and TMD.

psychological
Inspection of

the matrix reveals that the agreement between each dependent
variable on day 1 and day 2 was highly significant.

For example,

ACTH on Day 1 was highly related to ACTH on Day 2 ( £ < .001).
With only one modest exception, no significant associations were
revealed between the three response classes.

That is, ACTH (day 1
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Table 5
DBF Means and Standard Deviations for Type x Drua x Day
< N - 60)

ja

IZE®

8

A

no drug

1

76.25

11.83

8

A

no drug

2

72.00

8.28

20

A

drug

1

76.20

10.93

20

A

drug

2

75.60

8.45

10

B

no drug

1

77.40

7.24

10

B

no drug

2

79.00

8.60

22

B

drug

1

76.27

10.15

22

B

drug

2

77.54

10.79

Drug

Day

M

SD
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Table 6
HR Means and Standard Deviations for Type x Drug x Day
( N - 60)

n

Type

8

A

no drug

1

68.50

7.54

8

A

no drug

2

65.75

9.10

20

A

drug

1

68.45

10.44

20

A

drug

2

72.45

11.01

10

B

no drug

1

72.60

6.99

10

B

no drug

2

76.70

8.87

22

B

drug

1

67.23

11.86

22

B

drug

2

69.32

7.85

Drug

Day

M

SD
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Table 7
State Anxiety Means and Standard Deviations of Type x Drug x
Day

( N - 60)

jn

Type

Prog

8

A

no drug

1

36.25

6.54

8

A

no drug

2

32.25

7.40

20

A

drug

1

36.80

10.89

20

A

drug

2

35.10

9.01

10

B

no drug

1

36.70

11.45

10

B

no drug

2

34.20

10.81

22

B

drug

1

34.90

9.31

22

B

drug

2

33.36

9.10

Day

M

SD

80

Table 8
TMD Means and Standard Deviations of Type x Drug a Day
( N - 60)

ja

Type

Drug

8

A

no drug

1

150.50

32.74

8

A

no drug

2

148.62

33.96

20

A

drug

1

149.15

28.01

20

A

drug

2

140.05

27.25

10

B

no drug

1

149.90

26.70

10

B

no drug

2

147.60

20.22

22

B

drug

1

150.27

36.98

22

B

drug

2

144.86

31.00

Day

M

SD

Table 9
Pearson Correlation Matrix for all Dependent Variables
ACTH1

SBP1

DBP1

HR1

Statel

THD1

ACTH2

SBP2

0BP2

HR2

State2

ACTH1

SBP1

.08

DBP1

-.08

.63***

HR1

-.26

.11

.13

Statel

.07

.00

-.03

.23

TM>1

.14

-.01

-.05

.22

ACTH2

.58*** -.02

..03

-.22

.64***

.11

.14

SBP2

-.14

.49***

.36**

.27*

.17

.16

-.00

DBP2

..09

.39**

.50***

.27*

.16

.24

-.09

.71***

HR2

-.32**

.15

.21

.61***

.28*

.21

-.20

.05

State2

.01

.12

-.03

.20

.59***

.50***

-.04

.27*

.16

.13

TMD2

.04

.06

.28*

.55***

.70***

.07

.19

.18

.27*

-.02

*£ <.05, **p <.01, £ <.001
Mote.

All slfnlflcance levels Mere obtained using tvo-tailed tests.

.19

.78***

TW2
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or day 2) did not correlate with any of the cardiovascular or
psychological measures.

Similarly, cardiovascular masures on day

1 were not related to psychological measures on day 1.

Two

significant, but modest, correlations were revealed between
cardiovascular and psychological measures on day 2.
state anxiety (day 2) was related to SBP (day 2).
modestly associated with HR (day 2).

That is,

TMD (day 2) was

Regarding associations among

dependent variables within the same classification, it was found
that (a)

both self-report measures (state anxiety and TMD)

correlated highly with one another on day 1 and day 2; and (b)
measures of SBP and DBP on day 1 and day 2 were highly related,
but no significant correlations were revealed for HR.

With

respect to trait anxiety, significant correlations were revealed
with state anxiety on day 1 and day 2 ( £ < .0001) and with TMD on
day 1 and day 2 ( £ < .0001).

No significant correlations for

trait anxiety were noted among the biochemical measures or the
cardiovascular measures.

CHAPTER POUR
Discussion
The present stud/ was designed to investigate

physiological

and psychological reactivity to stress in JAS-assessed Type A and
Type B cardiac patients.

The evaluation of the effects of

medications on the response to stress was also an integral goal of
the current study.
N

Briefly, and with regard to the full sanple

(

» 60), significant day main effects were revealed for ACTH,

SBP, and state anxiety.

A significant main effect for drug and a

significant Type x Drug interaction was found for ACTH.

A

significant Type x Day interaction was revealed for SBP.
regard to the extreme sanple ( N

With

>30), significant main effects

for day were found for state anxiety and HR.

Because a different

pattern of results were noted for the full sanple and the extreme
sanple, these

findings will be discussed separately.

Full Sample
It was hypothesized that all patients would perceive the
catheterization day (day 1) to be more stressful than the
post-catheterization day (day 2).

The main effects for day, found

for ACTH, SBP, and state anxiety, provide support for this
hypothesis.

Patients, as a group, did respond to day 1 with

higher levels of ACTH, SBP, and anxiety ratings as ccnpared to day
2.

Although the mean differences between day 1 and day 2 on these

three measures were relatively small, the sanple size used in the
present study suggests that these differences were inportant and
noteworthy.

The data indicate, then, that the cardiac
83

84
catheterization did serve as a significantly stressful event for
the subjects.
It was predicted that Type As, as compared to Type Bs, would
exhibit greater responsiveness to the catheterization procedure.
This hypothesis was not supported in the present study.

This

failure to find differences between Type A and Type B subjects is
inconsistent with much of past research (e.g., Kahn et al., 1980;
Corse et al., 1982; and Krantz et al., 1982).

Consistent with the

present results are those studies from which negative findings
have been published (e.g., Steptoe et al., 1981; Case et al.,
1985).

A number of possibilities exist for this failure to find

A-B differences.

First, there is some evidence to suggest that

age nay be an important factor in reactivity to stress (Houston &
Ewart, 1984; Watkins & Eaker, 1986).

The research in this area is

controversial but most of the available data indicates that, with
increasing age, there is decreasing sensitivity to beta-adrenergic
stimulation.

This data would imply that, for at least

cardiovasular measures of reactivity, older individuals may appear
less responsive to stress.
is more speculative.

The association between ACTH and age

Because the size of the pituitary decreases

with age, there may be a correlation between inceasing age and
decreasing ACTH secretion (Daughaday, 1981).

The sample used in

the current study was comprised largely of older individuals ( M
= 53 years).

The use of an older population may have restricted

the range of responses to the stressor.

It is possible that a

younger sample may have exhibited more pronounced A-B differences.
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This would imply, as has been reccnraended recently in the
literature, that age factors should be more closely examined in
future reactivity research (Houston et al., 1984; Watkins et al.,
1986).
A second possible source of influence in the current data set
involves the effects that drugs (i.e., beta-blockers,
calcium-channel blockers, and both of these) had on the response
to the stressor.

The use of these drugs were associated with

lower ACTH responses in Type A individuals to levels consistent
with those shown by Type B subjects.

Because the greater

proportion of the study subjects were taking these target drugs,
it is possible that these drugs may also have restricted the range
of possible stress responses and/or served to further mask the
differences between Type As and Type Bs.

It should also be noted

that the effects of some drugs (e.g., nitrates) were not
systematically controlled.

It is possible that the effects of

uncontrolled medications also affected the current findings.

The

finding that drugs were associated with significantly reduced
responsiveness to the stressor strongly suggests that future
reactivity research control for these effects.
The failure in the current study to use extreme behavior
types may also have contributed to the lack of A-B differences.
There has been seme suggestion in the literature (Krantz et al.,
1984) that extreme Type As are more reactive to stress than
non-extreme Type A individuals.

The majority of this research has

been shown with the Structured Interview.

The use of extreme
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scores may be necessary to obtain more salient differences between
Type A and Type B subjects.

An attempt was made to explore this

possibility in the current study by conducting an additional
analysis of the dependent measures of those subjects scoring in
the extreme Type A and B range.

The failure to find significant

A-B differences in this case may have resulted fran the small
sample that was used ( N

» 30).

One final area of concern with respect to reasons for failing
to identify significant A-B differences involves those patients
who refused to participate in the study.

These patients,

approximately 15-20 in number, refused to participate for reasons
that, on an unsystematic observation, appeared anxiety-related
(e.g., fear of needles, too much to deal with during
hospitalization, too much paperwork, etc).
include these patients, fran whose

The inability to

verbal behavior one might

speculate anxiety and/or time urgency, may have also restricted
the range of responses to the stressor.

That is, Type As,

because of their impatient nature, may have been less willing to
participate in a time-consuning study.

This would hold especially

true for extreme Type As that would be expected to harbor the most
intense feelings of time urgency.

Future research aimed at

investigating individuals who refuse to participate in studies
would be helpful in determining posssible biases in study
populations.
The speculation that medications may have served to restrict
the range of responsiveness in the current study is indirectly
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supported by the findings of a significant drug effect and Type x
Drug interaction for ACTH.

Consistent with previous literature

(Durel et al., 1985), beta-blockers, calcium-channel blockers, and
both, were associated with reduced responsivity to the stressor in
all subjects (drug main effect).

Moreover,

the significant Type

x Drug interaction for ACIH indicated that the target drugs
differentially affected Type A and Type B subjects as was
predicted in the hypotheses.

Type As in the no drug condition of

the independent variable of drug group were more reactive (i.e.,
greater concentrations of ACIH) to the stressor than were Type As
in the drug condition.

The use of the target medications appeared

to have less of an inpact on Type Bs subjects because ACTH
concentrations were similar regardless of the drug condition
(i.e., drug or no drug).

These data suggest, then, that the

target drugs were more effective for Type A subjects.

It should

be noted that two inportant points make specific comparisons of
the current data to past research findings difficult.

First,

previous research on the effects of pharmacologic interventions on
stress have typically studied one drug at the time.

The current

study compared the effects of beta-blockers, calcium-channel
blockers, and both of these combined to a group of patients taking
neither of these drugs.

Second, previous Type A reactivity

research has, without question, neglected the investigation of
ACIH.

Given these considerations, it is difficult to compare the

current findings with those of previous research.

Nonetheless,

these results, suggesting that ACTH reactivity to stress can be
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reduced pharmacologically, can be considered as breaking new
ground for future research.

Seme degree of caution is necessary

in interpreting these results until future replications are
conducted.

However, the nature of the sample size ( N

* 48) and

the degree of significance ( £ < .003) for the Type x Drug
interaction would suggest that these results do not reflect
spurious findings.
Several important research and clinical implications can be
drawn from the drug main effect and the Type x Drug interaction
obtained for ACIH.

First from the standpoint of research, the

current data suggest that the control and evaluation of the
effects of various medications upon reactivity is necessary in
future research.

It is possible/ based on the current data, that

recent studies failing to find A-B differences (e.g., Komfeld et
al., 1985) may have resulted from an inadequate investigation of
drug effects.

From a clinical perspective, several implications

can be drawn from the current study.

One of the more exciting

areas of recent Type A research involves the hypothesis that
beta-blockers effectively modify Type A behavior to that more
consistent with Type B behavior patterns (Durel et al., 1985).
The current study provides indirect support for this hypothesis in
that drugs had the effect of reducing the responsivity of the Type
A subjects to that exhibited by Type B subjects.

Further, if one

accepts the evidence that Type A behavior is associated with an
increased risk of coronary heart disease, then the use of drugs
that could modify Type A behavior may decrease Type A related CHD
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risk.

There is evidence from the research of Brand et al. (1976)

that a 31 per cent reduction of CHD risk would would occur if the
direct risk associated with Type A were eliminated.

Therefore,

the use of beta-blockers, given continued supportive research, may
make a valuable contribution to reducing CHD.

Knowledge that

certain medications can substantially reduce the Type A
individuals' response to a stressful situation (e.g., surgery)
would also be useful information to the physician.

This knowledge

would be particularly beneficial if the stressor carried with it
dangerous side effects (eg., coronary artery bypass grafting).

In

situations such a major surgery, the use of medications to reduce
anxiety may lead to a lesser incidence of post-operative
complications.

Investigations of the combined efficacy of drugs

and well-known psychological methods of anxiety management could
be another avenue for research.
A significant Type x Day interaction was also found for SBP.
Inconsistent with previous research (Krantz et al., 1982;
Dembroski et al., 1977) and with the current hypotheses, SBP of
Type A subjects did not differ fran Type B subjects when exposed
to the stressor (day 1).

It is possible that the use of drugs in

the greater majority of patients served to restict the range of
SBP responsiveness to the stresses:.

Inconsistencies with previous

research (Jennings et al., 1984, Friedman et al., 1960) and the
current hypotheses were also found for SBP on day 2.

Research

would suggest that Type As and Bs should be similar during periods
of rest.

This was not supported by the current data.

It is
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unclear why Type A subjects, as ccnpared to Type B subjects,
demonstrated lower levels of SBP on day 2.
Extreme Sample
A very different pattern of results was observed using the
extreme sample.

In fact, the only significant findings for this

sample were day effects for state anxiety and HR.
for behavior type were revealed.

No main effects

This is inconsistent with

previous findings that extreme type As are more reactive to stress
than their non-extreme Type A counterparts (Krantz et al., 1984).
Two points should be noted regarding this analyses.

First, it was

not possible to investigate medications in this analysis.

As has

been suggested previously, the failure to investigate the effects
of medications may obscure A-B differences.

Second, extreme Type

As and Bs in the current study were identified in a slightly
different manner than is typically used in the current literature.
Typically, extreme scorers*are those falling one standard
deviation above (extreme Type A) or below (extreme Type B) the
mean on the Overall Type A score of the JAS.
quartiles were used in the present study.

Upper and lower

Whether or not this

modest difference in identifying extreme scorers accounted for the
lack of significant A-B differences is unknown and remains a
question for future research.

It should be noted, however, that

obtaining large sample sizes of extreme subjects is rather
problematic for the researcher interested in this area.
Correlational Data
A review of the Pearson correlation matrix suggests several
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points.

First, the correlation of each dependent variable with

itself (e.g., ACTH on day 1 correlated with ACTH on day 2) was
highly significant suggesting stability of each dependent measure
across both days of measurement.

As has been suggested, the use

of medications may have served to provide a ceiling effect on
arousal.

More importantly, perhaps, were the lack of significant

correlations among the biochemical, cardiovascular, and
self-report measures of arousal.

The lack of correlation among

different response channels of anxiety (i.e., physiological,
self-report, and motoric responses) is a reliable finding in the
anxiety literature (Neitzel & Bernstein, 1981).

Termed "response

desynchrony," the lack of correlation among response channels of
anxiety is thought to occur because the display of anxiety is a
result not only of the eliciting stimulus but of other factors as
well.

For example, in the present study, it is likely that,

although a subject may have felt subjective distress as a result
of the impending catheterization, the distress may not have been
reflected in the self-report measures because the subject may not
have wanted to appear distressed to the experimenter.

There was

also a lack of correlation among the physiological measures.
Although SBP and DBP were significantly associated with one
another, neither were found to be associated with HR.

These

findings are consistent with previous research as it is not
unccnmon for different physiological masures to correlate poorly
with one another (Lacey, 1967).

The occurrence of desynchrony

among response channels as well as within channels has

number of

92

indications.

First, the investigation of anxiety or arousal

requires multiple assessment methods.

Second, it is probably best

to avoid statistical methods of analysis that assume
intercorelations among dependent variables (e.g., multivariate
approaches).
Summary and Future Directions
The major contribution of the current study was the finding
that medications (i.e., beta-blockers, calciun-channel blockers,
and both combined) were associated with significantly reduced
responsivity to stress in Type A cardiac patients.

The

implications of this finding were discussed and the continued
control for and evaluation of the effects of medications upon
reactivity was emphasized.
Based on the current results, a number of future research
directions are inplicated.

First, systematic investigation

regarding the influence of age upon reactivity would be useful.
Second, a more thorough analysis of the effects of various drug
groups (e.g., beta-blockers, calcium channel blockers, nitrates)
upon reactivity is necessary before definitive statements can be
made.

Finally, future reactivity research is likely to benefit

from more frequent sampling of dependent measures, particularly
when endocrinological responses are assessed.
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Appendix A
INFORMED CONSENT AGREEMENT
I, _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ » do hereby consent to participate in
the study entitled "The Type A Behavior Pattern and ACTH
Response to the Stress of Cardiac Catheterization"* the
purpose of which is to investigate how different individuals
respond to cardiac catheterization* I understand that I have
been scheduled for cardiac catheterization on the advice of my
physician and that I am not being catheterized because of my
participation in the study* As such I will be signing a
separate consent agreement to undergo cardiac catheterization.
Other than procedures to be described below* my treatment
while hospitalized will be identical to that of any patient
hospitalized for cardiac catheterization.
Ms. Marie Veltia* M.S., psychology Intern under the
supervision of Dr. John Roitzsch* has explained to me verbally
the procedures* as described below* and I fully understand the
following:
A.

Procedure
1. Upon my consent to participate in the study* I will
be asked to complete a Personal Information Form which will
ask for demographic information (age* education, occupation)
and for information about the presence of traditional risk
factors (smoking history* family history of cardiovascular
disease* etc.).
2. I agree to complete the following questionnaires at
the times designated below. I understand that Ms. Veitia will
show me these forms as they are described.
a) Activity Survey (to be completed the evening before the
cathe terlzation
b) Anxiety Inventory (to be completed the morning prior to
catheterization and the morning after
c) Mood Inventory (to be completed the morning prior to
catheterization and the morning after)
All of these questionnaires are brief* each requiring 10-15
minutes or less to complete.
3) 1 agree to allow trained nursing personnel to draw
blood with a needle from a vein in my arm on two occasionsthe morning prior to catheterization and the morning after.
Approximately 10 cc (about two teaspoonfuls) of blood will be
drawn during each of the two blood drawing times. This blood
will be analyzed for chemicals (hormones) that occur during
stress.
4) I agree to allow Ms. Veltia to examine my medical
record to obtain other pertinent information (for example*
vital signs such as blood pressure and heart rate).
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B.
Duration : Upon my discharge from HUH, my participation
in the study will be completed.
C.
Possible Discomforts and/or Risks : The procedure to be
followed in the study are standard and non-experimental. When
blood is drawn from my arm, I may feel a slight pain and the
spot from which the blood is taken may be temporarily bruised.
There is a slight chance of inflammation of the vein and/or a
blood clot formation, but this is extremely rare.
There are
no risks associated with taking the psychological
questionnaires included in the study.
I understand that there
are risks associated with the cardiac catherization and these
will be explained to me on a separate consent agreement to
undergo this procedure, since undergoing the catheterization
itself has been scheduled for medical reasons and not for
purposes of this study.
D.
Possible Benefits : I understand that the study may not
benefit me directly, but will help scientists obtain new
knowledge that may benefit patients in the future.
1
understand that, if desired, an interpretation of my
psychological testing will be made available to me upon
completion of the study.
If I would like appropriate referral
, this will be made available to me.
Ms. Marie Veltia has agreed to answer any inquiries that 1 may
have concerning the procedures and has informed me that I may
also contact the Medical Unlveraity of South Carolina
Institutional Review Board for Human Research (803/792-4148)
directly concerning patient rights. This board administers
the agreement with the United States Department of Health and
Human Services covering the protection of human subjects.
I understand that in the event of any injury resulting from
the research procedures
to the participant, reasonable
medical treatment not otherwise covered by third party
payments will be available free through the Medical
University; financial compensation is not available for
medical treatment elsewhere, loss of work, or other expenses.

I may contact the Medical University of S.C. Hospital Medical
Director(803/792-3932) concerning medical treatment.
I understand that the participant's records of participation
in this study are not accessible to the general public and
confidentiality will be maintained. Information that may be
gained from this study will be used only for research and
educational purposes.
Information may be published with the
permission of the principal investigator in medical journals,
but the participant's identity will not be revealed. However,
identifying information will be available to monitors from the
MUSC I.R.B. for Human Research and the U.S. Food and Drug
Administration.

It is understood that participation is totally voluntary, and
I may choose not to participate.
I also understand that I am
free to withdraw my consent and discontinue participation at
any time.
Discontinuation will in no way jeopardise the
participant*8 ability to receive treatment now or in the
future at this institution.
I will receive a copy of the informed consent after it has
been read, understood, and signed.

DOCTOR OBTAINING CONSENT

SIGNATURE OF
PARTICIPANT

WITNESS

WITNESS

DATE OF CONSENT

SIGNATURE OF LEGAL
GAURDIAN
(if applicable)
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Appendix B
PERSONAL INFORMATION FORM
N A M E _________
DATE OF BIRTH

DATE ___________________
HEIGHT _____
WEIGHT

EDUCATION: ____ DID NOT GRADUATE HIGH SCHOOL
GRADUATED HIGH SCHOOL
COMPLETED TRADE SCHOOL
____ NO. OF YEARS
SOME COLLEGE
GRADUATED FROM FOUR YEAR COLLEGE
POSTGRADUATE WORK ____ HIGHEST DEGREE
CURRENT EMPLOYMENT STATUS:
FULL TIME
PART TIME
HOURS PER WEEK
UNEMPLOYED
RETIRED
YEAR
DISABLED
YEAR
DESCRIPTION OF PRESENT JOB:
Job Title
_ _ _ _ _ _ _ _ No. of years
hours per week ___

_ Average

ACTIVITY LEVEL: Which category listed below best describes
your current activity?
Which best describes your
activity in the past year?
1. Active: An athlete in training or a person who exercises
at a level comparable to running at least 10 miles per week or
a job involving heavy manual labor.
2. Moderately Active: Planned recreation, such as running,
swimming, bicycling, at least three days a week or a job
involving moderate activity, such as construction work or
farming.
3. Light Activity: Gardening, fishing, walking a mile most
days, or a job Involving walking or frequent step climbing.
4. Sedentary: Only normal daily activities such as eating,
sleeping, sitting, talking, attending school, or a sedentery
job.
SMOKING HISTORY: Do you smoke now (cigarettes, pipe, cigars)?
Yes, No
If cigarettes, how many packs per day? ____
Total number of years smoked?
____
FAMILY HISTORY: Does anyone in your family have (or had)
heart disease?
Whom?
Has anyone
in your family ever died of heart disease? __
At what age or
ages?
121
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ADDITIONAL RISK FACTORS:
High blood pressure
Diabetes
High dietary intake of fat
_____ High cholesterol or triglycerides
previous heart attack
WHAT ARE YODR CURRENT MEDICATIONS?
^circle as many aa apply)
NITRATES AND NITROGLYCERINS
Cardilate (oral)
Diltrate (oral)
Nitrong (oral)
NitroBid (oral)
Nitroglyn (oral)
Isordll (oral)
Sorbide (oral)
IsoBid (oral)
Duotrate (oral)
Pentritol (oral)
Peritrate (oral)
Ntrospan (oral)
Trldll (oral)
Cardabid (oral)
Nltrol Ointment
NitroBid Ointment
Nltrostat Ointment
Nitrong Ointment
Nitrodiac (transdermal)
Nitro-Dur (transdermal)
Transderm NTG (transderm)
Susadrin Tranamucosal tabs
BETA-BLOCKERS
Inderal (Propanolol HCL)
Vlsken (Pindolol)
Blockadren (Timolol maleate)
Corgard (Nadolol)
Lopressor (Metropolol)
Tenormin (Atenolol)
CALCIUM ENTRY BLOCKERS
Procardia (Nifedipine)
Iaoptln (Verapamil)
Calan (Verapamil)
Cardizem (Diltiazem HCL)
OTHERS:(Including psychiatric meds):

DOSAGE

FOR HOW LONG?

REASON FOR HEART CATH?
HATE YOU EVER HAD A HEART CATH BEFORE? Y OR N

If so, when?

HAVE YOU EVER HAD A CORONARY ARTERY BYPASS? Y OR N If so,
when?

115

Appendix C

Appendix Cl’ ACTH statistical Summary Table for 2 x 2 x 2 ANOVA
with Repeated Measures on Day { N - 48)

Appendix C2t

SBP Statistical Summary Table for 2 x 2 x 2 ANOVA

with Repeated Measures on Day ( N = 60)

Appendix C3:

DBP Statistical Suntnary Table for 2 x 2 x 2 ANOVA

with Repeated Measures on Day ( N * 60)

Appendix C4;

HR Statistical Sunmary Table for 2 x 2 x 2 ANOVA

with Repeated Measures on Day ( N ■ 60)

Appendix C5:

State Anxiety Statistical Sunmary Table for 2 x 2 x

2 ANOVA with Repeated Measures on Day ( N = 60)

Appendix C6s

TMD Statistical Sunmary Table for 2 x 2 x 2 ANOVA

with Repeated Measures on Day ( N - 60)
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Appendix Cl
ACTH Statistical Sunmary Table for 2 x 2 x 2

(Behavior Type x Drug

Group x Day) ANCWA with Repeated Measures on Day ( N - 48)

Source

df

MS

F

£

Type

1

2059.21

2.20

.14

Drug

1

4136.15

4.42

.04

Type x Drug

1

9003.73

9.63

.003

Day

1

2005.15

6.38

.01

Type x Day

1

747.91

2.38

.13

Drug x Day

1

117.39

0,37

.54

Type x Drug x Day

1

447.53

1.42

.24

S s (Type x Drug)

44

935.99

Day x S s (Type x Drug)

44

314.16
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Appendix C2
SEP Statistical Sunmary Table for 2 x 2 x 2

(Behavior Type x Drug

Group x Day) ANCVA with Repeated Measures on Day ( N ■ 60)

Source

MS

df

P

E

Type

1

234.57

0.56

.46

Drug

1

60.09

0.14

.71

Type x Drug

1

6.45

0.01

.91

Day

1

628.48

4.51

.04

Type x Day

1

890.77

6.39

.01

Drug x Day

1

43.55

0.31

.58

Type x Drug x Day

1

392.54

2.82

.10

S s (Type x Drug)

56

436.65

Day x S s (Type x Drug)

56

139.42
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Appendix C3
DBP Statistical Summary Table for 2 x 2 x 2

(Behavior Type x Drug

Group x Day) ANOVA with Repeated Measures on Day ( N - 60)

Source

df

MS

£

E

Type

1

159.26

1.09

.30

Drug

1

1.34

0.01

.92

Type x Drug

1

58.66

0.40

.53

Day

1

5.72

0.12

.73

Type x Day

1

92.36

1.94

.17

Drug x Day

1

16.97

0.36

.55

Type x Drug x Day

1

24.68

0.52

.47

S s (Type x Drug)

56

145.79

Day x s s (Type x Drug)

56

47.70
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Appendix C4
HR Statistical Suanary Table for 2 x 2 x 2

(Behavior Type x Drug

Group x Day) ANOVA with Repeated Measures on Day ( N =60)

Source

df

MS

F

£

Type

1

163.41

1.06

.31

Drug

1

60.77

0.39

.53

Type x Drug

1

587.50

3.80

.06

Day

1

89.60

2.39

.13

Type x Day

1

34.96

0.93

.34

Drug x Day

1

34.23

0.91

.34

Type x Drug x Day

1

119.71

3.20

.08

S s (Type x Drug)

56

154.08

Day x S s (Type x Drug)

56

37.43
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Appendix C5
State Anxiety Statistical Suimary Table for 2 x 2 x 2

(Behavior

Type x Drug Group x Day) ANOVA with Repeated Measures on Day
= 60)

Source

df

MS

F

£

Type

1

3.17

0.02

.88

Drug

1

0.83

0.01

.94

Type x Drug

1

56.68

0.39

.53

Day

1

148.23

3.97

.05

Type x Day

1

4.16

0.11

.74

Drug x Day

1

16.45

0.44

.51

Type x Drug x Day

1

2.82

0.08

.78

S s (Type x Drug)

56

146.10

Day x S s (Type x Drug) 56

37.38

(N
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Appendix C6
IMP Statistical Summary Table for 2 x 2 x 2

(Behavior Type x Drug

Group x Day) ANCWA with Repeated Measures on Day

Source

df

(N

= 60)

MS

P

£

Type

1

32.90

0.02

.88

Drug

1

233.92

0.15

.70

Type x Drug

1

89.21

0.06

.81

Day

X

556.90

2.03

.16

Type x Day

1

18.35

0.07

.80

Drug x Day

1

165.92

0.61

.44

Type x Drug x Day

1

26.43

0.10

.76

56

1575.74

S s (Type x Drug)

Day x S s (Type x Drug) 56

274.25

Appendix D

Appendix Dl:

ACTH Statistical Sunmary Table for 2 x 2 ANOVA with

Repeated Measures on Day { N = 22)

Appendix D2:

SBP Statistical Sunmary Table for 2 x 2 ANOVA

with Repeated Measures on Day ( N * 30)

Appendix D3:

DBP Statistical Sunmary Table for 2 x 2 ANOVA with

Repeated Measures on Day ( N = 30)

Appendix D4:

HR Statistical Summary Table for 2 x 2 ANOVA with

Repeated Measures on Day ( N * 30)

Appendix D5:

State Anxiety Statistical Sunmary Table for 2 x 2

ANOVA with Repeated Measures on Day ( N = 30)

Appendix D6:

TMD Statistical Sunmary Table for 2 x 2 ANOVA with

Repeated Measures on Day ( N * 30)

12.2
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Appendix D1
ACIH Statistical Santary Table for 2 x 2
ANOVA with Repeated Measures on Day

Source

df

. MS

(N

(Behavior Type x Day)
■ 22)

I

£

Type

1

5.24

0.01

.94

Day

1

280.18

0.75

.40

Type x Day

1

278.20

0.74

.40

S s x Day (Type) 20

374.99

Appendix D2
SBP Statistical Stannary Table for 2 x 2
ANOVA with Repeated Measures on Day

Source

df

MS

(N

(Behavior Type x Day)
= 30)

F

£

Type

1

928.27

2.66

.11

Day

1

224.27

1.77

.19

Type x Day

1

317.40

2.51

Day x S s (Type) 28

126.37
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Appendix D3
DBP Statistical Sunmary Table for 2 x 2
ANCWA with Repeated Measures on Day

Source

df

MS

(N

(Behavior Type x Day)
* 30)

F

£

Type

1

147.27

1.26

.27

Day

1

24.07

0.55

.47

Type x Day

1

19.27

0.44

.51

28

43.67

Day x £ s (Type)
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Appendix D4
HR Statistical Summary Table for 2 x 2
with Repeated Measures on Day

Source

df

(N

MS

(Behavior Type x Day) ANOVA

=30)

F

£

Type

1

60.00

0.39

.54

Day

1

166.67

4.30

.05

Type x Day

1

60.00

1.55

.22

28

38.76

Day x S s (Type)
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Appendix D5
State Anxiety Statistical Suwnary Table for 2 x 2
Day) ANOVA with Repeated Measures on Day

Source

df

(N

(Behavior Type x

= 30)

MS

F

£

Type

1

96.27

0.76

.39

Day

1

153.60

4.07

.05

Type xDay

1

0.60

0.02

.90

Day x Ss (Type)

28

37.74
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Appendix D6
TOD Statistical Suimary Table for 2 x 2
ANOVA with Repeated Measures on Day

Source

df

Type

MS

1

(N

(Behavior Type x Day)
* 30)

£

£

64.07

0.04

.84

Day

1

405.60

2.86

.10

Type x Day

1

395.27

2.79

.11

Day x S s (Type) 28

141.90
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